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ABSTRACT 
African trypanosomes are protozoan blood parasites that infect both humans and 
livestock. BALB/c mice are highly susceptible to experimental infections by Trypanosoma 
congolense while C57BL/6 mice are relatively resistant, as measured by degree and pattern of 
parasitemia and survival time. Rapid death observed in highly susceptible BALB/c mice is due 
to a systemic inflammatory response syndrome (SIRS). A small subset of pathogenic, MHC 
class II-restricted CD4+ T cells, activated during the course of T. congolense infections, 
mediates early mortality in infected highly susceptible BALB/c mice via excessive synthesis 
of the cytokine IFN-γ. Since these pathogenic T cells are matrix–adherent, they could be 
distinguished from conventional Th1 cells.  There is a possibility that this subpopulation of T 
cells has unique surface markers.  
The complement system is highly activated in African trypanosomiasis, leading to 
persistent hypocomplementemia. Amplification of the alternative pathway of complement is 
faster in BALB/c mice than in C57BL/6 mice and the degradation of complement component 
C3b to complement component C3d, during the amplification of the alternative pathway of 
complement, proceeds faster in BALB/c than in C57BL/6 mice (Ogunremi et al., 1993). T. 
congolense-infected BALB/c mice have more immune complexes containing trypanosomal 
variant surface glycoprotein (VSG) than C57BL/6 mice in their plasma (Pan & Tabel, 
unpublished).  T. congolense-infected BALB/c mice might have more VSG-C3d immune 
complexes than infected C57BL/6 mice. The receptor for complement component C3d is the 
cell surface molecule CR2, also referred to as CD21. It is known that CR2 is widely expressed 
on B lymphocytes and follicular dendritic cells. There is also some evidence that CR2 is 
expressed on a subpopulation of activated T cells. Binding of VSG-C3d immune complexes to 
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the complement receptor CR2 might costimulate the CR2+ T cells to produce IFN-γ.  I 
hypothesize that IFN-γ-producing T cells in T. congolense-infected BALB/c mice are CR2+ 
and that the CR2+ T cells increase in numbers in experimental murine T. congolense 
infections. 
Kinetic studies were carried out by staining spleen cells of  T. congolense-infected 
BALB/c mice for the presence of CR2 on T cells (CD3+ cells). Total numbers of spleen cells 
showed a 5-fold increase with progressive T. congolense infections. The total numbers of T 
cells in the spleen showed a 7-fold increase at day 8 post infection. The total numbers of CR2+ 
T cells in the spleen showed a 3 to 7-fold increase with progressive infection. Parallel studies 
on B lymphocytes (CD19+ cells) showed that absolute numbers of B cells in the spleen had a 5 
to 6-fold increase with progressive infection.  Absolute numbers of CR2+ B cells in the spleen 
showed a 4-fold increase at day 7 post infection. The total numbers of CR2+ cells in the spleen 
showed an increase while the mean numbers of CR2 molecules per cell showed a reduction 
with progressive infection. 
These results show that CR2+ T cells in the spleen increase in numbers with 
progressive T. congolense infections in BALB/c mice. I suggest that CD4+CR2+ T cells might 
play a role in the pathogenesis of T. congolense infections.  
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1.0 LITERATURE REVIEW 
1.1. African Trypanosomes 
1.1.1. Introduction 
African trypanosomes are single-cell, extracellular blood parasites that cause disease 
and death in humans and livestock. Trypanosoma brucei gambiense and Trypanosoma brucei 
rhodesiense cause sleeping sickness in humans. Trypanosoma congolense, Trypanosoma 
brucei brucei and Trypanosoma vivax are pathogens for livestock. Of  these species T. 
congolense is the most virulent pathogen in livestock,  causing the greatest losses in livestock 
(Mulligan, 1970a; Mulligan, 1970b).  
 African trypanosomes are mainly transmitted to mammalian hosts by tsetse flies. The 
occurrence of animal trypanosomiasis coincides with the distribution of tsetse fly vectors 
which includes the regions between latitudes 14°N and 29°S. About 10 million square 
kilometers and 37 countries are covered in this tsetse fly “belt”, a geographical area equivalent 
to the combined size of the United States, India and Western Europe (Hursey, 1995). 
 African trypanosomiasis causes a great economic loss in the livestock industry with an 
estimated three million cattle death annually. Estimated direct production losses in cattle are 
between US$ 6,000 million and US$ 12,000 million per year (Hursey, 1995). It is estimated 
that if the disease is controlled, the region could support a further 120 million cattle resulting 
in an increase in annual meat production by 1.5 million tons (Nantulya, 1986).  
 Currently employed control methods of trypanosomiasis are chemotherapy, breeding 
resistant breeds of cattle and control of tsetse fly vectors. Other control methods include bush 
clearing to destroy the tsetse fly habitats, spraying insecticides and trapping of tsetse flies 
(Taylor, 1998). But the control measures like bush clearing and the use of insecticides are no 
longer desirable due to their deleterious effects on the environment. Even though the first 
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trypanocidal drug was developed in 1905, the number of drugs available for the treatment of 
African trypanosomiasis is very limited (Seed, 2001).  Rapid evolution of drug-resistant 
trypanosomes reduces the efficacy of chemotherapy and chemoprophylaxis causing 
widespread outbreaks in cattle (Leach and Roberts, 1981; Holmes, 1982).  
 Vaccination is considered to be one of the best methods of controlling infections. 
Presently, it is widely believed that the ability of African trypanosomes to continually express 
antigenically distinct VSG genes (Borst et al., 1997) reduces the likelihood of the development 
of an effective VSG-based vaccine. Therefore, invariant parasite antigens are being considered 
as vaccine candidates but only partial and minimal cross-protection has been reported so far 
(Mkunza et al., 1995). Mice immunized with the recombinant beta-tubulin from T. evansi, 
were protected from lethal challenge with T. evansi STIB 806, T. equiperdum STIB 818 and T. 
brucei brucei STIB 940, showing 83.3%, 70% and 76.7% protection, respectively (Li et al., 
2007). A better understanding of the parasite and host factors involved in pathogenesis of the 
disease might be helpful in the design of more effective vaccines against trypanosomiasis. 
Therefore, most research is focused on understanding the pathogenesis of the disease, 
especially the induction of immunosuppression by the infection.  
1.1.2 Classification 
 African trypanosomes are flagellated protozoal parasites belong to the class 
Zoomastigophores, order Kinetoplastida and family Trypanosomatidae. Members of the order 
Kinetoplastida are elongated, slender and possess a single nucleus and a kinetoplast situated 
near the origin of the single flagellum. The pathogenic trypanosomes belong to the genus 
Trypanosoma. The subgenus Trypanosoma is divided into two sections on the basis of their 
life cycle in the insect vector and the mode of transmission (Hoarse, 1972). 
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 The section salivaria consists of the trypanosomes that complete their developmental 
cycle in the salivary glands of their insect vector. Transmission of the parasite to the 
mammalian host occurs by bite of the insect vector during a blood meal. The section salivaria 
consists of four subgroups; Duttonella (T. vivax), Nannomonas (T. congolense), Trypanozoon 
(T. brucei brucei) and Pycnomonas (T. suis). Most members of the group salivaria are 
transmitted by tsetse flies and they are important pathogens either to man or to domestic 
animals.  
  The section stercoraria consists of groups that complete their developmental cycle in 
the hindgut of the insect vector. Transmission of these species occurs when the feces 
containing the infectious metacyclic form of the parasite is rubbed into the lesions produced at 
the site of the insect bite. Also, they may actively penetrate punctures made by the proboscis 
of the insect or the mucous membrane of the mouth if the animal licks the feces of the vector. 
There are three sub groups in the section stercoraria namely, Megatrypanum (T. theileri), 
Herpestoma (T. lewisi and T. musculi) and Schizotrypanum (T. cruzi) (Hoarse, 1972).  T. cruzi 
causes Chagas disease in man in South and Central America while most of the other members 
of section stercoraria are considered relatively non-pathogenic.  
1.1.3 Morphology and characterization 
 African trypanosomes are characterized on the basis of their size, shape, position of the 
nucleus, size and location of the kinetoplast, host range and geographical distribution. 
Generally they are elongated, spindle-shape organisms with a single flagellum. The flagellum 
originates from the basal body near the kinetoplast and runs the length of the trypanosome. 
The pellicle, the layer bordering the cytoplasm, while maintaining a definite shape, is flexible 
enough to permit a certain degree of body movement. The pellicle and the cytoplasm are 
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pinched up into a thin sheet of tissue along the length of the body forming the undulating 
Membrane (Hoarse, 1972). 
 African trypanosomes are 8-30 μm in length. T. congolense is a small monomorphic 
organism with variable length of 8-24 μm (Soltys, 1987). It has a central nucleus and a 
medium sized marginal kinetoplast. The kinetoplast has important functions in reproduction 
and metabolism (Hoarse, 1964). The trypanosome has sluggish movements and has an 
undulating membrane (Hoarse, 1972; Soltys, 1987).  
1.1.4 Life cycle 
 The life cycle of African trypanosomes consists of two phases. One is the development 
in their insect vectors and the other phase is the development in mammalian hosts.  
1.1.4.1. Development in insect vectors 
Transmission of African trypanosomes is mediated by tsetse flies (Glossina species). 
The genus Glossina consists of three groups called fusca group (forest group), palpalis group 
(riverine group), and morsitans group (savannah group). These three groups have more than 
34 species and subspecies and T. congolense is capable of developing in all of these species 
and subspecies (Hoarse, 1972). The female tsetse fly acquires a trypanosomal infection during 
a regular blood meal from an infected mammalian host. The ingested parasites lose their VSG 
and undergo a series of developmental and morphological changes resulting in multiplication 
in the hindgut of the fly (Stephen, 1986). They migrate interiorly through the cell linings of the 
gut wall and to the esophagus of the insect (Newton et al., 1973). Then they migrate to the 
hypopharynx and transform into the epimastigote form (Newton et al., 1973). The 
epimastigotes migrate into the mouth pads of the proboscis and transform into metacyclic 
trypanosomes. This transformation is associated with the regaining of the VSG which the 
trypanosomes lost in the midgut (Vickerman, 1974). The entire developmental cycle in the 
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insect vector may take from 7 (Nantulya et al., 1978) to 53 (Hoarse, 1972) days depending on 
the species of the  insect vector and the ambient temperature. The infected tsetse fly harbors 
the parasite and is able to transmit the parasite for a considerable length of time and 
sometimes, for life (Molyneux, 1983).   
1.1.4.2. Development in mammalian hosts 
 Infection of the mammalian host occurs when the insect vector deposits metacyclic 
trypanosomes within the dermal connective tissue of the animal during a blood meal. At the 
site of infection the trypanosomes multiply extensively as typical blood forms within a few 
days, resulting in a raised cutaneous swelling called a chancre (Akol and Murray, 1982). 
These trypanomastigotes spread from the chancre via the blood and local lymph vessels and 
enter to the blood stream. Blood stream forms of many T. brucei invade the connective tissues 
of the mammals, but this is not usually observed with T. congolense (Losos and Ikede, 1970).  
 Certain changes in the metabolism during the period of growth in the blood stream 
results in morphological pleomorphism among various subspecies of T. brucei (Opperdoes, 
1987).  Morphological variants ranging from long slender forms to short, stumpy, usually non-
dividing forms could be found during the process of active cell division. Frequently observed 
intermediate forms may represent a transition stage from long slender form to stumpy form 
(Opperdoes, 1987). Predominate slender forms could be seen during the early logarithmic 
phase of infection (Lumsden, 1972) while the stumpy forms predominate during the phase of 
parasite remission (McLintock et al., 1990). It has been suggested that the transformation of 
slender forms to the stumpy forms is necessary for the cyclical development in the insect 
vector (Seed and Sechelski, 1989). Even though there are reports on morphological variants of 
T. congolense (Stephen, 1986), the general agreement among researchers is that T. congolense 
does not undergo physical transformation.  
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1.1.5. Course of the infection 
 Clinical signs and the severity of the disease following infection vary depending on the 
virulence of the trypanosome and susceptibility of the host. The length of the prepatent period 
depends on many factors such as the number of infecting parasites, the route of inoculation 
and the genetic makeup of the host. Parasitemia becomes apparent within 1-2 weeks following 
natural infections and may persist for months, occurring in waves, until the host dies (Gray, 
1976).  Various strains of trypanosomes can cause a wide range of clinical responses ranging 
from acute, chronic to asymptomatic carrier syndromes (Stephen, 1970; Maxie et al., 1979). 
Even under similar environmental conditions, marked differences in susceptibility of 
individual animals within a homogenous population could be observed (Ikede and Losos, 
1972).  
 Acute infection of T. congolense in ruminants is associated with intermittent fever, 
depression, anemia, subcutaneous edema of the mandible and prominent jugular pulse 
(Stephen, 1970; Losos, 1986). The appetite is decreased and there is a rapid weight loss. 
Often, death is related to severe anemia and circulatory collapse. Chronic syndromes often 
results in extreme emaciation and anemia. Lymphadenopathy is commonly seen in infections 
with other species of trypanosomes but not common in T. congolense infections in cattle 
(Maxie et al., 1979). The more rapid fall in myeloid:erythroid ratio in T. congolense-infected 
goats reflects the fact that T. congolense causes more severe pathological effects in goats than 
T. brucei (Biryomumaisho and Katunguka-Rwakishaya, 2007).  
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1.1.6. Pathology 
 There are no pathognomonic gross or histopathological lesions found in the animals 
that die of trypanosomiasis. Most of the observed lesions are due to the circulatory 
disturbances caused by anemia. Mice infected with T. congolense developed a severe anemia 
one week after infection which was accompanied by a marked increase in the plasma levels of 
acute phase proteins such as serum amyloid P component and haptoglobin (Ngure et al., 
2008).  Animals that die of acute infections have variable atrophy of muscle and adipose 
tissues and pale carcasses. Often the lymph nodes, spleen and the liver are enlarged.  Also, 
there may be edema of the lungs, ascitis, hydrothorax and hydropericardium (Stephen, 1970; 
Molyneux, 1983; Losos, 1986).   The skeletal muscles of the carcass may be wasted and pale 
in chronic cases. Marked splenomegaly with foci of necrosis and prominent white pulp is also 
observed in chronic cases (Morrison and Murray, 1979; Valli et al., 1979). Inflammatory foci 
are found in spleen, liver, lung, heart, skeletal muscles, brain, skin and kidney.  
 Even though the mechanisms of pathogenesis of trypanosomiasis is not clearly 
understood, trypanosome-derived substances and immune complexes comprising trypanosome 
antigens and parasite-specific IgM and/or IgG antibodies plus complement were shown to be 
involved in the pathogenesis (Mansfield, 1990).  Immune complexes have been detected in 
several tissues of infected animals and humans including heart, brain, kidney and skeletal 
muscles (Lambert, 1974; Nagle et al., 1974). It has been suggested that trypanosomes generate 
toxic catabolites and biologically active metabolites with complement activating and 
inflammatory properties, such as cytokines, vascular amines and plasma proteases which can 
contribute to the pathogenesis of the disease (Tizard and Holmes, 1976; Tizard et al., 1978; 
Tabel, 1982; Liu et al., 1993). Highly susceptible BALB/c mice infected with T. congolense 
die of a systemic inflammatory response syndrome (SIRS) that is mediated by IFN-γ (Shi et 
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al., 2003; Shi et al., 2005). This SIRS was associated with elevated plasma levels of IL-6, IL-
12p40, IL-10, and IFN-γ. Focal liver lesions of apoptotic parenchymal cells, 5-fold 
enlargement of Kupffer cells, apoptosis of 10% of Kupffer cells, enlarged capillary bed, 
hypotension, decreased body temperature, piloerection, hypomotility and death were also 
associated with SIRS (Shi et al., 2006a). 
1.1.7. Trypanosomal common antigens  
 The trypanosomal antigens can be divided into two groups namely invariant or 
common antigens and variant antigens, based on their immunological specificity.  Invariant 
antigens of trypanosomes do not change from one variant type to another type during the 
course of infection. These include enzymes, trypanosomal membranes, structural and  nuclear 
proteins and some receptors such as those for transferrin and low density lipoproteins (Pays et 
al., 1994), high density lipoproteins, receptor for TNF-α (Lucas et al., 1994) and receptor for 
IFN-γ (Olsson et al., 1993). Some enzymes such as  phospholipase C (Fox et al., 1986) and 
peptidases (Knowles et al., 1989) are common to all species of trypanosomes. The 
conservation of these enzymes suggests that they may be important for the survival of 
parasites and also they might play a role in pathogenesis and/or evasion of host defense 
mechanisms. The carbohydrate determinants in  the C-terminal portion amino acid sequence 
of the variant surface antigen (VSG) is also considered as a common antigen  and show a high 
degree of homology among the members of a species (Rice-Ficht, 1981; Rice-Ficht et al., 
1982). Flagellar pockets of African trypanosomes are not covered by the VSG and are 
invariant among the members of a species. In cattle, immunization with antigens derived from 
flagellar pockets of T. brucei rhodesiense resulted in significant protection against challenges 
with T. congolense and T. vivax (Mkunza et al., 1995). Since the flagellar pockets are not 
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covered by VSG, it is clear that the immune response to VSG is not included in this 
protection.  
 
It has been suggested that the invariant antigens released by destruction of the parasite 
by anti-VSG antibodies and other immune factors, may be involved in inducing pathology by 
forming immune complexes (Mansfield, 1990). However, in T. congolense-infected cattle high 
serum antibody levels to 33kd (Authie et al., 1993) and 69kd (Boulange and Authie, 1994) 
invariant cystein proteases have been associated with trypanotolerance.  T. congolense-
infected trypanosusceptible Boran cattle mounted predominant IgM response to invariant 
proteins while similarly infected trypanotolerent N’dama cattle made a superior IgG and low 
IgM response (Authie et al., 1993). Crosses between Boran and N’ dama cattle which are of 
intermediate susceptibility had intermediate levels of these antibodies (Mkunza et al., 1995).  
1.1.8. Variant surface glycoprotein (VSG) 
 The plasma membrane of trypanosomes is covered by a homogenous dense coat called 
variant surface glycoprotein, consists of millions of glycoprotein molecules of a single 
molecular species.  
1.1.8.1. Organization of the VSG gene 
 The genome of African trypanosomes contains about 1000 different VSG genes (Van 
der Ploeg et al., 1982). Only one VSG gene is expressed at a time in a given bloodstream 
parasite under normal conditions (Munoz-Jordan et al., 1996). The unexpressed VSG genes 
are scattered among the different chromosomes (Cross et al., 1998). VSG genes need to be 
located in a specialized telomeric environment, which is known as a bloodstream telomere-
linked VSG gene expression site (BES) in order to be transcribed. Bloodstream VSG genes 
have been found to be transcribed from telomere-linked expression sites and contain a VSG 
9 
 
promoter, a variable number of 70-76 bp repeats, and the VSG gene is followed by 
subtelomeric and telomeric DNA repeats (Kang et al., 2002). At any time, only one BES is 
active and only one VSG gene is transcribed. The molecular events in a given trypanosome 
that induce transcription at one BES and silence expression at the other BESs are not 
understood (El-Sayed et al., 2000).  
1.1.8.2 Structure of VSG 
 The molecular weight of VSG varies between 53-65 KD and VSGs of different variant 
antigen types of the same serodeme may differ in their amino acid composition, isoelectric 
points and carbohydrate percentage (Cross, 1978; Cross, 1990). Tryptic digestion of the C 
terminal portion of the VSG molecule can reduce the MW from 53 to 48 kDa. In the insect, 
VSG is only expressed in infective metacyclic form (Vickerman, 1974) and it has been 
proposed that the VSG prevents the lysis of metacyclic forms by the host’s serum factors 
(Ghiotto et al., 1979). VSGs, cover the entire parasite surface, and are arranged in a tightly 
packed monolayer of homodimers. They form a 12-15 nm thick coat which functions as a 
barrier to lytic serum components but allows nutrients such as glucose to reach transporters in 
the membrane of the flagellar pocket (Borst and Fairlamb, 1998). Each parasite has107 densely 
packed identical VSG molecules on their surface (Cross, 1990; Gerold et al., 1996). VSG 
constitute about 10% of the total protein of trypanosomes and is synthesized at a high rate 
(Kang et al., 2002). VSG is very immunogenic and therefore the target of the very potent 
immune response (Vanhamme et al., 2001).  
 Each VSG monomer contains an N-terminal signal sequence and a hydrophobic C- 
terminal domain and is covalently attached to a glycosylphosphatidylinositol (GPI) membrane 
anchor (Kang et al., 2002). Many proteins of eukaryotes are anchored to the plasma membrane 
by the GPI, including Thy 1 antigen and decay-accelerating factor (McConville and Ferguson, 
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1993). N-terminal sequence of VSG is highly variable. The three-dimensional structures of the 
N-terminal two-thirds of two VSGs have been determined by  X-ray crystallography and 
found to be very similar rod-like shapes despite having quite different amino acid sequences 
(Blum, 1993). The VSG molecules can be cleaved by trypanosomal GPI-specific 
phospholipase C. This GPI-PLC cleaves the GPI anchor, leaving the dimyristoylglycerol 
compound of the GPI anchored in the membrane, and releases the glycosyl-inositol-phosphate 
(GIP)-VSG part which is also called soluble VSG (Magez et al., 1998). 
1.1.8.3. Release of soluble VSG 
 VSG could be detected in the plasma of mice and rats infected with T. brucei brucei 
(Diffley et al., 1980) indicating that trypanosomes release their VSG during the course of 
infection. Even though the VSG coats are stably associated with the plasma membrane of the 
trypanosomes, it can be isolated as membrane form of VSG (mVSG) (Bulow and Overath, 
1986) or as the water soluble form (sVSG) after lysis of the cells. mVSG is converted into 
sVSG during the lysis of cells by the action of an endogenous enzyme, GPI-specific 
phospholipase C (GPI-PLC) (Ferguson, 1999). GPI-PLC is involved in degradation, shedding 
and recycling of VSG (Carrington et al., 1991; Rolin et al., 1996).  
 Trypanosomal lysates contain vast amounts of sVSG produced from mVSG by the 
action of GPI-PLC, which gains access to mVSG by hypotonic lysis of the cells (Fox et al., 
1986). However, the role of GPI-PLC in hydrolysis of GPI is still not clear because cytosolic 
GPI-PLC is localized away from cell surface VSG. GPI-PLC null mutants are fully viable, and 
GPI-PLC null mutants undergo antigenic variation (Cardoso De Almeida et al., 1999). It was 
shown that shedding of VSG is mediated by hydrolysis of GPI. Surface biotinylation assays 
suggest that GPI-PLC does gain access to extracellular VSG. The above results indicate the 
importance of GPI-PLC in release of VSG (Gruszynski et al., 2003).  
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 The cell surface VSG pool is turned over within 12 minutes. Recycling of VSG 
happens through endocytosis in large clathrin-coated vesicles that bud from the flagellar 
pocket membrane, and then are delivered to endosomes or lysosomes. The VSG returns to the 
cell surface at the flagellar pocket by exocytosis (Engstler et al., 2004).  
 Antibodies against T. congolense can induce shedding of soluble VSG and the 
formation of a soluble covalent complex of VSG and bovine complement component C3b, in 
the presence of fresh bovine serum (Liu et al., 1993).  
1.1.8.4 Effect of VSG on the immune system of the host 
 10% of the total protein content of trypanosomes consists of GPI-linked VSG. Since 
the trypanosomes are extra cellular parasites and they release vast amounts of sVSG into the 
circulation, the immune system of the infected mammalian host is continuously exposed to the 
sVSG (Magez et al., 2002).  There is evidence that blood stream forms of T. congolense evade 
complement lysis by shedding their immune complexes (Frevert and Reinwald, 1990) and 
endocytosis of immune complexes (Engstler et al., 2007). VSG of T. brucei cause 
consumption of complement proteins, which may occur via the massive amounts of immune 
complexes generated during antibody-mediated clearance of each wave of parasitaemia 
(Musoke and Barbet, 1977). Immunostimulatory and regulatory activity of protozoan derived 
GPI anchors has been documented (Ropert and Gazzinelli, 2000). It has been suggested that 
soluble VSG which carries the carbohydrate core (GIP-VSG), once released from the parasite 
surface, is affecting the functions of macrophages, including induction of cytokine synthesis 
(Magez et al., 2002). It has been shown that NO is trypanostatic for T. congolense, T. musculi, 
T. gambiense and T. brucei in vitro (Vincendeau et al., 1992; Kaushik et al., 1999a). Soluble 
VSG could inhibit IFN-γ induced nitric oxide production by macrophages (Coller et al., 2003).  
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All the above findings suggest that sVSG released from the parasites has negative effects on 
control of the infection.   
1.1.9. Antigenic variation 
 Highly immunogenic nature of VSG leads to a strong humoral immune response 
resulting in rapid elimination of all but a very small proportion of trypanosomes. These 
remaining individuals form a new population expressing a new variant of VSG. When the new 
population of parasites multiplies, the immune system raises another set of antibodies to 
eliminate these parasites and eventually eliminates the majority of these parasites. This 
process results in successive waves of parasitemia (Donelson and Turner, 1985). The 
undulating wave of parasitemia in infected animals is a result of interactions between the 
parasite and the host’s immune factors. It has been shown that antibodies are not necessary to 
induce antigenic variation because antigenic variation has been observed in vitro (Doyle et al., 
1980). In established rodent strains, it is estimated that coat switching occurs at a frequency of 
10-6-10-7 per cell division and this rate is much higher immediately after passage through 
insect vectors (Barry and Turner, 1991).   
 Even though the precise molecular events lead to the antigenic variation are still not 
understood, it is clear that antigenic variation is advantageous to the parasite in its evasion of 
the host immune defenses because the host is always a step behind the switching 
trypanosomes.  
1.2. Immune responses of hosts against African trypanosomes 
 African trypanosomes are exposed to the host immune system from the time of 
infection. Since a single trypanosome is a package of about 10 million copies of a single VSG 
and thousands of invariant antigens (Vickerman, 1985), the immune system of the host is 
continuously assaulted by excessive amounts of invariant and variant antigens.  
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1.2.1. Innate resistance 
 Antigen-nonspecific defense mechanisms that are designed to recognize highly 
conserved structures present in many different microorganisms and called pathogen-associated 
molecular patterns, are considered to be a form of  innate immunity (Aderem and Ulevitch, 
2000). Trypanotolerance or the resistance to African tryapanosomiasis is characterized by 
lowered parasitemia and less marked anemia (Dargie et al., 1979). A/J and BALB/c mouse 
strains are susceptible for T. congolense infections while C57BL/6 mouse strain is relatively 
resistant. The speed of control of the first wave of parasitemia positively correlates with the 
survival period of infected mice (Ogunremi and Tabel, 1995). In response to T.congolense 
infections, macrophages of susceptible BALB/c mice produce less amounts of nitric oxide 
than the macrophages of relatively resistant C57BL/6 mice (Kaushik et al., 1999a). The 
differences in susceptibility and resistance in BALB/c and C57BL/6 mice is controlled by five 
quantitative trait loci namely Tir1, Tir2, Tir3a, Tir3b and Tir3c, located on mouse 
chromosomes 17, 5 and 1 (Iraqi et al., 2000).  
1.2.1.1. Role of complement system 
1.2.1.1.1. Complement system  
Complement is a major clearance and defense system in the blood which can be 
activated via immunoglobulins once a foreign particle or an organism has been recognized by 
the antibody (Law, 1988). The alternative complement pathway can be amplified directly via a 
foreign particle or an organism while the classical complement pathway gets activated via 
antigen-antibody complex as summarized in Figure 1.1. Complement is an important 
component in host immune system which functions together with the adaptive immune 
responses to provide effective defense mechanisms such as killing microorganisms by lysis, 
14 
 
initiating inflammation and facilitating the clearance of microorganisms and immune 
complexes by facilitating phagocytosis (Law, 1988) .  
The complement system is composed of more than 30 plasma and membrane-
associated proteins as well as receptors for complement components (Table 1.1). Complement 
component C3 (M.W. = 185kD) is the central component of complement system and it is the 
most prevalent complement component in the serum being  present at a concentration about 
1.3 mg/ml. C3 plays a central role in the complement system by merging the classical and 
alternative pathways at the C3 activation step (Law, 1988). Both classical and alternative 
pathways can activate the same terminal complement pathway (C5-C9) which leads to the 
formation of the membrane attack complex and cause cytolysis (Rother, 1988).  
The crucial intermediate step of the complement activation is the formation of C3/C5 
convertase. Activated C3, referred as C3b opsonizes the target by covalently binding to it and 
facilitates the phagocytosis of the target. When C5b is generated, it induces the assembly of 
C5b-C9 membrane attack complex. Biologically active cleavage products such as C3a, C4a 
and C5a cause inflammation and anaphylactic activities.   
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C5b-9 membrane attack complex  
 
 
Figure 1.1. The activation steps of the classical pathway (left) are triggered by immune 
complexes, while the alternative pathway (right) is amplified by a wide variety of cell surfaces 
and compounds. Adapted from (Law, 1988).  
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 Table 1.1 Proteins of the human complement system  
 
Prevalent 
Functional group 
 
Participate in Receptors 
activation 
Regulatory 
form 
Seru ble C1q, C1r, C1s, C4, C1 INH, C4bp, H, I,  m/solu
C2, C3, B, D, C5, C6, 
C7, C8, C9 
P, C3a/C5a INA, S 
protein 
Membrane- CP, DAF, C1qR, CR1, CR2, 
associated 
 CR1, M
HRF CR3, CR4, CR5, 
C3a/C4aR, C5aR 
 
bbreviations: INH, Inhibitor; C4bp, C4b-binding protein; INA, inactivator; R, receptor, e.g. A
CR2 complement receptor 2; DAF, decay-accelerating factor; MCP, membrane cofactor 
protein; HRF, homologous restriction factor. Adapted from (Volanakis, 1990).  
 
 
 
 
 
 
 
17 
 
1.2.1.1.2. The classical complement pathway 
way needs antigen-antibody complexes. These 
m from 
 Activation of classical complement path
antibodies in human could be from IgM class, IgG1, IgG2 and IgG3 subclasses. Complement 
components C1, C4 and C2 are responsible for the assembly of C3 convertase. C1 is a 
calcium-dependent macro-molecular complex of three distinct sub components: Clq, Clr and 
Cls (Lepow et al., 1963). Clq is a glycoprotein and consists of 18 polypeptide chains linked 
together by disulphide bonds. Clr and Cls are single chain serine proteinases, connected 
together with Clq via calcium (Cole, 1988). Interaction of the Cl complex with antigen-
antibody complex via C1q activates C1r and C1s proenzymes. C4 binds C2 in a magnesium-
dependent manner after releasing fragment C4a with the influence of activated C1. The bound 
C2 is also cleaved by the C1, resulting in formation of active C3 convertase, C4b2a. This 
C4b2a cleaves C3 by releasing a small peptide C3a. The large remaining fragment C3b 
contains a labile binding site through which C3b binds covalently with a nearby target surface. 
Then, C5 combines with the attached C3b and as a result, modifications take place in C5 to 
make it susceptible to get cleaved by the neighboring C4b2a enzyme. Activation of C5 is 
followed by the formation of C5b-9 cytolytic complex (Vogt et al., 1978; N.C., 1986). 
 C1 inhibitor is a control protein that can bind with C1r and C1s to remove the
the C1-antibody-antigen complex and inactivate the C1 enzymatic activity. C4b binding 
protein is another control protein which regulates the classical pathway C3 convertase as well 
as fluid-phase and cell bound C4b by binding to C4b and making it prone to get cleaved by 
factor I (Hourcade et al., 1989). EDTA can inhibit the activation of classical complement 
pathway by chelating Ca2+ and Mg2+ to prevent the assembly of C4b2a.  
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1. 2.1.1.3. The alternative complement pathway 
cal and alternative pathways is that the 
nitiation of alternative pathway occurs by 
y depends on 
 The major difference between the classi
alternative pathway can be activated in the absence of antibodies and can neutralize a wide 
variety of microorganisms in the absence of specific antibodies. The process of activation of 
the alternative pathway can be divided into four phases: initiation, deposition of C3b, 
recognition and amplification (Pangburn, 1986). 
 Under the normal circumstances, the i
hydrolysis of the intra-molecular thiolester bond of C3. This leads to the formation of C3 
(H2O). C3 with a hydrolyzed thiolester, without the loss of its C3a fragment, is called C3i or 
C3 (H2O). This is continuously produced under normal conditions at a very low rate in 
aqueous phase. C3 (H2O) has the same functional properties of C3b and it forms a complex 
with factor B in an Mg2+-dependent manner. The cleavage of B into Bb by factor D is 
followed by the formation of C3 convertase with the composition C3 (H2O) Bb (Pangburn and 
Muller-Eberhard, 1980). This convertase enzyme is capable of forming a small number of 
metastable C3b molecules in the fluid phase but most of these metastable C3b molecules 
rapidly get inactivated by factor H and I. Some of the C3b molecules non-specifically bind 
with any particles including host cells. The C3b bound to the host cells are eliminated and 
inactivated by factor I and membrane associated regulators. C3b bound to foreign particles are 
recognized as the proper sites of activation and serve as anchors for the assembly of the 
surface-associated convertase enzymes of the alternative complement pathway.  
 Recognition of activator or non-activator surfaces of alternative pathwa
the nature of the surface to which C3b is bound (Pangburn et al., 1980; Meri and Pangburn, 
1990). The alternative pathway amplification loop is restricted to certain surfaces as a result of 
the balance of interactions between complement proteins. Non-activating surfaces permit the 
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control proteins to prevent the formation of C3bBb complex either by displacement of Bb 
from C3b or by cleavage of C3b into iC3b (figure 1.3). Activation surfaces have the common 
but unidentified property of providing the action of control proteins on C3bBb, allowing the 
positive feedback C3 activation loop to operate on the surface as shown in figure 1.3 (Law, 
1988).     
1.2.1.1.4. Central role of C3 
in in the complement system since the classical and alternative 
) release C3f (3kd) once acted on by factor I and 
 C3 is the central prote
pathways merge at the C3 activation step. C3 is a β-globulin composed of an α chain and a β 
chain. The molecular weight of C3 is 185 kD. In the classical pathway, C3 is activated by the 
proteolytic cleavage of C3 into C3a and C3b. The removal of C3a induces conformational 
changes in C3b which leads to the exposure of internal thiolester which is quite inaccessible in 
native C3. The exposed thiolester is very reactive and subjected to nucleophilic attack by 
water or the amino or hydroxyl groups of other molecules. If these hydroxyl or amino groups 
belong to the cell surface molecules, C3b become covalently bound to the cell by an amide or 
an ester bond (Law, 1988). Surface-bound C3b, generated by the classical pathway has the 
same convertase activity as C3b generated by the alternative pathway and both pathways share 
the effector mechanisms such as the generation of anaphylotoxin C5a, engulfment of C3b-
coated particles by phagocytotic cells having C3b receptors and the generation of C5b which 
mobilizes C6, C7, C8 and C9 to form the membrane attack complex.  
1.2.1.1.5. Breakdown products of C3 
 Membrane bound C3b (185 kd
cofactors leaving iC3b attached to the membrane. Serum proteases or factor I in association 
with CR1 react with iC3b to release C3c and leave C3dg (40kd) attached to the membrane. 
Exogenous proteases release C3g (5kd) to leave C3d (35 kd) attached to the membrane as 
20 
 
shown in Figure 1.3. Complement’s physiological effects, except the lytic event mediated by 
membrane attack complex, are generated by the interaction of the complement fragments with 
their specific receptors present on specialized cells. The major outcomes of the complement 
fragment-receptor interaction are the uptake and phagocytosis of opsonised particles and the 
activation of the cell type bearing the specific receptor for each complement fragment.   
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Figure 1.2. Amplification loop is restricted to certain surfaces by a balance of 
interactions between complement proteins. (a) In the fluid phase activation is curtailed by 
efficient cleavage of C3b by factor I and cofactors. (b) Surface bound C3b on non-activators is 
regulated similarly and in addition C3bBb is actively dissociated by factor H, CR1 and DAF. 
(c) On activator surfaces these two regulatory pathways are inhibited and rapid deposition of 
C3b on the surface ensues. Adapted from Law and Reid, 1988).  
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Figure 1.3. Breakdown of C3b. Adapted from Law and Reid, 1988)     
 
1.2.1.1.6. Receptors for breakdown products of C3 
1.2.1.1.6.1. CR1 
 CR 1 (CD35) is a single chain transmembrane protein that binds C3b. CR1 is highly 
expressed on monocytes, B cells and eosinophils while it is expressed in low amounts on 
erythrocytes and T cells. Human CR1 is genetically polymorphic and occurs in four different 
molecular weights ranging from 190-280 kD (Wong et al., 1983; Ross and Medof, 1985; Ross, 
1989). Binding of immune complexes to phagocytes via CR1 mediates phagocytosis as well as 
cell activation. CR1 on human erythrocytes allows immune complexes in the circulation to 
attach to erythrocytes for transport to phagocytes in the spleen and liver, leading to their 
clearance. Rodent platelets express CR1, which performs a similar transport function (Roitt, 
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2001). CR1 promote dissociation of C3bBb and also act as a cofactor for factor I which 
cleaves C3b into small fragments thereby act as a complement regulatory protein (Roitt, 
2001). Soluble form of CR1 has been used in human clinical trials in acute respiratory distress 
syndrome, and to reduce tissue damage in lung transplantation and myocardial infarction 
(Zamora et al., 1999; Zimmerman et al., 2000).  
1.2.1.1.6.2. CR2 
 CR2 (CD21) is a 145 kD transmembrane protein which acts as the receptor for C3d, 
the final degraded product of C3. CR2 primarily acts as a B cell co-receptor for antigen 
receptor-mediated signal transduction (Holers, 2005). CR2 is composed of 15 or 16 short 
consensus repeats  followed by a 28 amino acid transmembrane domain and a relatively short 
intra cytoplasmic tail (Holers, 2005). In mice, CR1 and CR2 are transcribed from the 
alternative splicing of a single gene located on chromosome 1 while in humans they are 
derived from closely linked two distinct genes located on chromosome 1(Boackle, 2005). No 
activation signal has been discovered that induces the alternative splicing of one form over the 
other (Zabel and Weis, 2001).  
In mice, CR2 is predominantly expressed on B cells, follicular dendritic cells and 
activated granulocytes (Kinoshita et al., 1988; Carroll, 1998). Mouse CR2 is also expressed on 
peritoneal and splenic B-1 cells. Human CR2-expressing cells include mature B cells, double-
negative thymocytes, a subset of CD4 and CD8 thymic and peripheral T cells, follicular 
dendritic cells, basophils, mast cells, keratinocytes and epithelial cells (Holers and Boackle, 
2004). In human and mice, expression of CR2 first appears during IgMhighIgDlow immature B 
cells. This stage specific expression of CR2 is controlled by an intronic silencer in both human 
and mice (Holers, 2005). The expression of this receptor on mouse T cells has been less well 
documented (Qian et al., 2005). CR2 was expressed on activated T cells in A/J mice (Chen et 
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al., 2005). A subset of CD44hiCD62Llo T cells, but not naïve CD44loCD62Lhi T cells, 
expressed CR2 suggesting that these receptors were directly or indirectly involved in the 
expression of activation markers on B and T cells and T cell proliferation (Kaya et al., 2001). 
CR2 was detectable on both CD4+ and CD8+ subsets of T cells (Kaya et al., 2005). In T cells, 
CR2 may act either as an activating receptor or, more likely, as an adhesion molecule to 
promote the recruitment or retention of tissue-infiltrating cells (Holers, 2005).  
Human CR2 has at least four unique classes of ligands including, cleaved C3 activation 
fragments (Iida et al., 1983; Weis et al., 1984), Epstein-Barr virus via the surface protein 
gp350, 220 (Fingeroth et al., 1984; Nemerow et al., 1989), the immunomodulatory protein 
CD23 (Aubry et al., 1992) and interferon-α (Delcayre et al., 1991). Mouse CR2 demonstrates 
an altered ligand repertoire because, while it binds C3 activation fragments identically to the 
human receptor, it does not bind gp350/220 of Epstein Barr Virus or mouse CD23. It is not yet 
known whether mouse CR2 binds IFN-α (Holers, 2005). Ziya Kaya et al (2001) suggested that 
CR2 is necessary for optimal activation of B and T cells because CR-/- mice showed lower 
expression of activation markers on both B and T cells and decreased amounts of T cell 
cytokines, such as IL-2, IL-4 and IFN- γ, after antigen stimulation.  
CR2 has been shown to have multiple effects on B and T cell responses, including the 
amplification of antigen-induced B cell activation through surface IgM, the rescue of 
peripheral B cells from IgM-mediated apoptosis (Kozono et al., 1995), the promotion of 
antigen processing and presentation of C3d-bound targets, modulation of the expression of 
costimulatory molecules and targeting of immune complexes to germinal centers in secondary 
lymphoid organs. It is likely that many of these functions occur through interactions of CR2 
with CD19 and CD81 on B cell surface, where these receptors form a multimolecular signal 
transduction complex. CR2 on both B cells and follicular dendritic cells are required for the 
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generation of normal T-dependent antibody responses (Boackle, 2005). B cell lines expressing 
higher levels of CR2 were more efficient in processing antigen than those with lower levels. 
These findings suggest that presentation of antigen by B cells in immune individuals is 
dependent on the binding of complement-antigen immune complexes to CR2 (Boackle et al., 
1997). Although not investigated, the complexes of cleavage products of complement 
component C3 (C3b, iC3b and C3d) and soluble or particulate trypanosomal antigens might 
have a profound effect upon binding to cells bearing receptors for C3b, iC3b and/or C3d 
(Tabel et al., 2000).  
Mesenteric lymph nodes of wild type C57BL/6 mice contain about 4-5% of CR2+ 
CD4+ T cells while this population is not detected in CR2 deficient mice (Molnar et al., 2008). 
Elevated expression of CR2 is found on apoptotic T cells. Binding of 7G6 monoclonal anti-
CR2 antibody to T cells induced NF-κB translocation to the nucleus (Molnar et al., 2008).  
1.2.1.1.6.3. CR3 
 CR3 is the receptor for C3bi and this receptor is located on phagocytic cells and 
natural killer cells. CR3 is composed of two non-covalently linked glycoprotein chains of an α 
subunit named CD11b and a β subunit named CD18 (Sanchez-Madrid et al., 1983). CR3 
expresses two binding sites, one for Arg-Gly-Asp-containing peptides and the other one is for 
bacterial LPS (Wright et al., 1989).  
 CR3 is the major, but not the only, receptor involved in IgM anti-VSG-mediated 
phagocytosis of T. congolense by macrophages and IgM anti-VSG-mediated phagocytosis of 
T. congolense enhances the synthesis of TNF-α  but inhibits the synthesis of trypanocidal NO. 
It has been suggested that signaling of inhibition of NO synthesis might be mediated via CR3 
(Pan et al., 2006).  
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1.2.1.1.6.4. CR4 
 CR4 is the predominant type of C3 receptor expressed on tissue macrophages that 
frequently lack detectable levels of CR1 and CR3, and plays the same role as CR3.  CR4 is 
composed of two subunits named as CD11c and CD18 (Taborda and Casadevall, 2002). CR4 
can act as another C3bi and C3d receptor of phagocytic cells and it is functionally distinct 
from CR2 but similar to CR3 (Myones et al., 1988).  The binding site on CR4 is calcium 
dependent (Corbi et al., 1988).  
1.2.1.1.7. Complement interaction with parasites 
 It is difficult to form a general overview on the possible role of complement system 
against the numerous different types of parasite infections. Many parasites appear to activate 
the alternative complement pathway, and this would be amplified by the presence of specific 
antibodies against the parasites. In some cases, complement may provide beneficial effects to 
the parasites. One such example is by allowing entry into host cells of C3b-and/or iC3b-coated 
parasites (Leishmania) via CR1 and/or CR3 on host cells. Side effects due to activation of 
complement by immune complexes can lead to nephritis in malaria (Law, 1988).   
1.2.1.1.8. Complement interaction with trypanosomes 
 Complement mediated lysis of trypanosomes was observed in vivo and in vitro 
(Vickerman, 1982). In cattle, trypanosomal infections are accompanied with severe depression 
of hemolytic complement activity (Tabel et al., 1980). Depression of hemolytic complement 
activity is more prominent in susceptible cattle than in trypanotolerant cattle (Authie and 
Pobel, 1990). Complement depletion in the serum probably contributes to increased 
susceptibility of secondary infections in trypanosome-infected animals (Maxie et al., 1979). 
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Homogenates of T. congolense or trypanosomes lacking their glycoprotein coat could activate 
alternative pathway of complement (Tabel, 1982; Ferrante and Allison, 1983).  
 Both the classical pathway and alternative pathways of complement are activated 
during African trypanosomiasis (Greenwood and Whittle, 1980). Even though the clearance of 
trypanosomes by phagocytic cells occur in the absence of complement (Ngaira et al., 1983), 
the efficiency of immune complex removal and parasite clearance is enhanced by complement 
(Stevens and Moulton, 1978). Severe impairment of hepatic uptake of opsonized T. brucei 
brucei has been observed in mice depleted of C3 by treatment with cobra venom factor 
(Macaskill et al., 1980). But, partial depletion of C3 in T. brucei brucei -infected mice 
(Shirazi, 1980) or T. brucei rhodesiense (Dempsey and Mansfield, 1983) had no effect on 
controlling parasitemia or phagocytosis.  
 Hypocomplementemia is a marked feature of African trypanosomiasis in cattle (Tabel, 
1982), sheep (Malu and Tabel, 1986) and mice (Otesile et al., 1991). Total hemolytic 
complement activity and C3 are more reduced in trypanosusceptible Zebu than in 
trypanotolerant Baoule cattle (Authie and Pobel, 1990). Preinfection levels of factor H was 
significantly higher in resistant C57BL/6 mice than in susceptible BALB/c mice and the 
amount of factor B in plasma of infected mice during the later stages of infection showed a 
positive correlation with survival time and was higher in trypanotolerant C57BL/6 mice 
(Otesile et al., 1991). The activity of alternative pathway of complement amplification 
measured by deposition of complement protein C3b demonstrated that deposition of C3b was 
significantly higher in the plasma of resistant C57BL/6 mice than in BALB/c mice infected 
with T. congolense and the degradation of C3b to C3d during the amplification of the 
alternative pathway of complement proceeds faster in BALB/c than in C57BL/6 (Ogunremi et 
al., 1993). C5-sufficient and C5-deficient mice did not show significant differences in either 
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hepatic uptake of parasites (Macaskill et al., 1980) or in their survival periods (Jones and 
Hancock, 1983), indicating that complement mediated lysis does not play a major role in 
resistant to trypanosomiasis.  
  1.2.1.2. Role of nitric oxide (NO) 
 NO is a free radical gas which acts as a nonspecific cytotoxin in the host immune 
system (Moilanen and Vapaatalo, 1995).The small and lipophilic  nature of NO facilitates its 
entrance into microbes. The primary targets of NO are sulfhydryls and iron which is central to 
the biochemistry of microbes (MacMicking et al., 1997). NO produced by activated 
macrophages is considered to be an important arm of non-specific immunity (May and 
Machesky, 2001).  
 Different pathogens or stimuli use different signaling pathways for NO production. It 
has been shown that Fc receptors (Bayon et al., 1997), mannose receptors (Karaca et al., 1995) 
and Toll-like receptors (Mizel et al., 2003) can all affect NO synthesis. It has been shown that 
NO is trypanostatic for T. congolense, T. musculi, T. gambiense and T. brucei in vitro 
(Vincendeau et al., 1992; Kaushik et al., 1999a). Bone marrow derived macrophages and 
peritoneal macrophages of resistant C57BL/6 mice produce more NO than the macrophages of 
susceptible BALB/c mice in T. congolense infections (Kaushik et al., 1999a). In T. brucei- 
infected highly susceptible mice, NO has been reported to be partially responsible for 
macrophage-mediated splenic immunosuppression (Mabbott et al., 1995) but this is not true 
for T. congolense-infected mice (Uzonna et al., 1998b). The upregulation of NO is not found 
in cattle during T. congolense infection and was not responsible for the reduction of T cell 
proliferation (Taylor et al., 1998).  T. congolense–infected iNOS-/- C57BL/6 mice were 
considerably more susceptible than wild-type C57BL/6 mice, suggesting a role for NO in 
parasitemia control in vivo. Interestingly, the iNOS-/- mice were not as susceptible to T. 
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congolense infections as IFN-γ-R-/- mice were, suggesting that the protective role of IFN-γ 
signaling would extend beyond its function in iNOS activation (Magez et al., 2006). IgM anti-
VSG-mediated phagocytosis of T. congolense enhances the synthesis of TNF-α but inhibits 
synthesis of parasite-controlling NO (Pan et al., 2006).  
  1.2.1.3. Role of macrophages 
 Clearance of the trypanosomes from the circulation is predominantly achieved by 
phagocytosis of the opsonized parasites by macrophages in the liver (Kupffer cells) and to 
some extent by macrophages of the spleen (Holmes et al., 1979; Macaskill et al., 1980; 
Macaskill et al., 1981; Dempsey and Mansfield, 1983). After phagocytosis, trypanosomes are 
rapidly digested in the phagolysosomes of the Kupffer cells (Mansfield, 1990). In 
trypanosome infections, the numbers of macrophages are increased in liver, spleen and lymph 
nodes (Clayton et al., 1980; Murray and Dexter, 1988).  
It has been suggested that macrophage membrane Fc receptors for IgG and 
complement receptors play a role in mediating phagocytosis of trypanosomes. In in vitro 
studies, procyclic forms of T. brucei adhered readily to mouse peritoneal macrophages in the 
absence of antibodies and this attachment was mediated by a non-Fc, non-C3 receptor on the 
plasma membrane of macrophages suggesting that ligands for macrophage receptors may be 
present on trypanosomal plasma membranes (Mosser and Roberts, 1982). T. brucei is taken up 
by monocytes in vitro, in the presence of IgM or IgG anti-VSG antibodies in the absence of 
complement (Ngaira et al., 1983; Rurangirwa et al., 1986). This indicates that both Fc 
receptor-dependent and independent mechanisms might play a role in phagocytosis. It has 
been suggested that binding of IgM antibodies to the trypanosome surface causes activation of 
complement and due to the deposition of C3 cleavage products on trypanosomes results in 
phagocytosis of trypanosomes via the macrophage receptors for C3 cleavage products (Devine 
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et al., 1986; Mansfield, 1990). This has been shown to occur when IgM antibodies bind to 
VSG of T. congolense (Pan et al., 2006).  It has been shown that CR3 (CD11b/CD18) is the 
major receptor for IgM antibody-mediated phagocytosis of African trypanosomes and this 
phagocytosis is complement dependent (Pan et al., 2006). IgM anti-VSG-mediated 
phagocytosis of T. congolense enhances synthesis of disease-producing TNF-α but inhibits 
synthesis of parasite-controlling NO. This inhibition of synthesis of NO is dependent on CR3 
but is independent of complement (Pan et al., 2006).  
There were no significant differences observed in phagocytosis of trypanosomes by 
macrophages and monocytes of T. congolense-infected N’Dama and Boran cattle suggesting 
that even though phagocytosis is the primary mechanism involved in the control of parasites, 
factors other than phagocytosis dictate or contribute to the differences between resistant and 
susceptible animals (Sileghem, 1991). During experimental murine trypanosomiasis, the 
induction of costimulatory cytokines such as IL-1 and IL-2 were found to be depressed in both 
susceptible and resistant mouse strains (Mitchell et al., 1986). In another study, the induction 
of costimulatory cytokines was increased from monocytes and macrophages of T. congolense-
infected cattle (Sileghem et al., 1993). Trypanosome-mediated early activation of 
macrophages may lead to stimulate trypanosome-specific helper T cells and non-specific 
stimulation of T cells as a result of elevated costimulatory cytokines (Mansfield, 1990). 
Continued stimulation of macrophages by T cell-derived cytokines (IFN-γ) or autoregulatory 
factors like TNF-α, IL-10 and prostaglandins could interfere with further stimulation of T cells 
(Mansfield, 1990; Sileghem et al., 1994a; Uzonna et al., 1998b). Activation of macrophages 
and down regulation of macrophages in trypanosomiasis may occur in a T cell-independent 
manner since these are observed in infected congenitally T cell deficient athymic mice 
(Mansfield, 1990).   
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Susceptibility of mice to T. congolense and T. brucei infections can be suppressed by 
treatment with macrophage stimulants such as LPS, BCG, Bordetella pertussis and 
Corynebacterium parvum before the infection suggesting that the trypanosomes may be 
controlled by non-specific mechanisms of activated macrophages (Singer et al., 1964; Murray 
and Morrison, 1979). Upon activation, macrophages produce certain molecules which have 
microbicidal properties such as reactive oxygen intermediates (ROIs), reactive nitrogen 
intermediates (RNIs) and TNF-α (Adams and Hamilton, 1984; Auger, 1992). In C57BL/6 
mice, IL-10 produced by FoxP3+ Tregs regulate classical activation of the macrophages 
resulting in reduced TNF-α production and this was beneficial for the host survival by limiting 
the tissue damage (Guilliams et al., 2007).   
Phagocytosis of T. congolense by Kupffer cells of the liver leads to rapid activation of 
the Kupffer cells with release of monokines and enlargement of Kupffer cells (Shi et al., 
2004). There is very little trypanosomal antigen detectable in the liver and the Kupffer cells 
are not visibly enlarged up to day 5 post-infection. However, at day 6, there is a prominent 
accumulation of parasite antigen in Kupffer cells and the Kupffer cells are enlarged (Fig 1.4). 
There was a 5-fold increase in size of the Kupffer cells towards the terminal stage of infection 
and about 10% of the Kupffer cells undergo apoptosis (Shi et al., 2005).  
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1.2.2. Adaptive immune responses 
 Adaptive immunity or acquired immunity is an antigen-specific defense mechanism 
consists of two major categories; humoral immunity and cell mediated immunity.  
1.2.2.1 Humoral immune responses 
 Humoral immunity is mediated by antibody molecules produced by B lymphocytes in 
response to antigens. Specific B cell responses against VSG surface epitopes represent 
composite T cell-dependent and T cell-independent processes (Reinitz and Mansfield, 1990). 
The T cell-independent B cell responses are associated with temporary immunity to the variant 
antigenic types of trypanosomes arising during acute and chronic infections (Campbell and 
Phillips, 1976; Pinder et al., 1986; Reinitz and Mansfield, 1990).  The contribution of T cell-
independent and T cell-dependent processes to the total antibody production during infections 
is variable (Reinitz and Mansfield, 1990). Nude BALB/c and C57BL/6 mice, which lack T 
cells, are able to control the first wave of parasitemia (Campbell and Phillips, 1976; Pinder et 
al., 1986).  
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 Fig. 1.4. Accumulation of trypanosomal antigens in Kupffer cells of the liver. BALB/c mice 
were infected with 103 T. congolense VAT TC13 i.p. Mice were killed on days 0–7 post-
infection. Peroxidase stain for trypanosomes (A–C): No trypanosomal antigen was detected on 
day 0 post-infection (A). The earliest time of detection of trypanosomal antigens was on day 5 
(B). Accumulations of parasite antigens significantly increased on day 6 (C). Peroxidase stain 
(anti-F4/80) for Kupffer cells (D–F): Kupffer cells appeared not visibly enlarged up to day 5 
(D, E). In contrast, Kupffer cells were markedly enlarged on day 6 (F). Original magnification, 
X 400 (Shi et al., 2004). 
 
 
 
34 
 
 The B cell specific responses to VSG result in elimination of trypanosomes expressing 
the target surface antigen and control parasitemia. In the presence of specific antibody, 
trypanosomes are rapidly eliminated from the circulation (Mansfield, 1990; Shi et al., 2004). 
The resistant mice exhibit marked production of VSG-specific antibodies during an infection 
(Levine and Mansfield, 1984; Newson et al., 1990), while mice highly susceptible for 
trypanosomiasis were found to have little or no detectable antibodies against VSG (Black et 
al., 1983; Morrison and Murray, 1985) even though their B lymphocytes are extensively 
activated.  The primary immune responses to VSG consists of both IgG and IgM classes of 
antibodies and reaches the maximum in 7-14 days following challenge (Roelants and Pinder, 
1984).  During the initial parasitemic wave, IgM was the only detectable class of antibody 
(Dempsey and Mansfield, 1983). Highly immunogenic VSG can induce high amounts of IgM 
in infected mice and cattle (Radwanska et al., 2000). The massive IgM production is not 
accompanied by a concomitant increase in production of IgG antibody in susceptible BALB/c 
mice (Uzonna et al., 1999).  
 During early onset  of T. brucei infection in mice, spleen remodeling results in a rapid 
loss of IgM+ marginal zone B cell population characterized as 
B220+IgMhighIgDintCD21highCD23lowCD1d+CD138- (Radwanska et al., 2008). When these 
cells were isolated during the first peak of infection, they were stained positive for Annexin V 
and had increased caspase-3 enzyme activity. Increased caspase-3 mRNA levels coincided 
with decreased levels of anti-apoptotic Bcl-2 mRNA and BAFF receptor, indicating the onset 
of apoptosis. Also, affected B cells become unresponsive to stimulation by B cell receptor 
cross-linking with anti-IgM Fab fragments and infection-induced loss of IgM+ B cells 
coincided with the absence of protective variant-specific T-independent IgM responses, 
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rendering the host susceptible to re-challenge with previously encountered parasites 
(Radwanska et al., 2008).  
1.2.2.1.1. Role of antibodies  
 The production of antibodies against various predominant VSGs provides protective 
immunity in infected animals (Naessens, 2000). VSG-specific antibodies mediate 
complement-mediated lysis (Flemmings and Diggs, 1978; Crowe et al., 1984) and increase the 
uptake of trypanosomes by macrophages (Ngaira et al., 1983; Shi et al., 2004). The clearance 
of the parasites is an immune-mediated mechanism and needs VSG-specific antibodies (Pinder 
et al., 1986). Blood stream trypanosomes are protected against phagocytosis in the absence of 
antibodies (Mosser and Roberts, 1982). Antibodies against non-variant antigens may 
neutralize toxic or pathogenic effects of certain trypanosomal molecules and may prevent 
anemia after repeated infections (Paling et al., 1991). In a study of T. congolense infections in 
BALB/c mice, Otesile and Tabel (1987) concluded that variant-specific antibody is necessary 
but not enough to control the infection.  
 Highly susceptible BALB/c mice produced IgM antibodies to common trypanosomal 
epitopes earlier than the resistant C57BL/6 mice. But BALB/c mice failed to switch to 
produce IgG2a and IgG3 antibodies (Uzonna et al., 1999). When infected mice were treated 
with Berenil, they produced IgG3 and IgG2a antibodies against trypanosomal common 
epitopes. Mice that underwent self cure had the highest levels of IgG3 and IgG2a antibodies 
against common trypanosomal epitopes (Uzonna et al, unpublished). When T. congolense and 
IgG2a anti-VSG were added to macrophage cultures, the induction of NO production by the 
macrophages was 2 to 9 fold higher than the production of NO by the macrophages added with 
T. congolense and IgM anti-VSG antibodies (Kaushik et al., 1999a). IgM is more efficient 
than IgG in complement-mediated lysis of T. brucei (Seed, 1977). In in vitro studies, IgG and 
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IgM  had equivalent effects on phagocytosis but had different effects on macrophage 
activation (Kaushik et al., 1999b). 
 When mice were infected with purified VSG or non-multiplying trypanosomes, 
resistant and susceptible mice produced almost similar amounts of anti-VSG antibodies with 
identical kinetics (Morrison and Murray, 1985; Pinder et al., 1986). Resistant cattle produce 
more IgG antibodies against VSG and invariant antigens than susceptible cattle (Authie et al., 
1993; Taylor et al., 1996) while susceptible mice made higher IgM antibody responses (Taylor 
et al., 1996; Williams et al., 1996). Superior IgG responses to invariant antigens are associated 
with enhanced resistance in trypanotolerant cattle breeds (Authie et al., 1993; Agur and Mehr, 
1997). 
1.2.2.2 Cellular immune responses 
1.2.2.2.1. T cells  
 T cells are central to the regulation and activation of immune responses. Mature T cells 
show heterogeneity functionally as well as by the expression of CD4 and CD8 molecules 
(Reeves G., 1996). The T cells which cooperate with B cells, helping them to respond to the 
antigens, resulting in differentiation of B cells into antibody-secreting plasma cells are termed 
helper T cells. Distinct sub populations of T helper cells preferentially promote T cell 
immunity (TH1) or stimulate antibody production (TH2) based on the cytokines they produce 
(Reeves G., 1996).  
 Some T cells are able to suppress immune responses and therefore are designated 
suppressor T cells. Some other T cells are able to kill the cells expressing foreign determinants 
on their surfaces and to kill virus-infected cells, and are named cytotoxic T cells (Reeves G., 
1996).  
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1.2.2.2.2. Role of T cells in protection against African trypanosomiasis 
 The role of T cells in protection against African trypanosomiasis is poorly investigated. 
The VSG surface epitope-specific B-cell responses in mice infected with trypanosomes 
represent composite T-cell-dependent and T-cell-independent processes, and a significantly 
stronger response is made in the presence of T cells (Reinitz and Mansfield, 1990). The 
synthesis of IgG2a but not IgM anti-parasitic antibodies were reduced in CD4-/- BALB/c mice 
infected with T. congolense (Shi et al., 2006a) supporting the idea that IgM production is 
predominantly CD4+ T cell independent and the switch from IgM to IgG2a requires help from 
CD4+ T cells.  
IFN-γ in T. congolense infections of mice is mainly produced by matrix-adherent 
splenic CD4+ T cells (Uzonna et al., 1998c). Experiments carried out using IFN-γ knock-out 
mice showed that IFN-γ is required for the survival of relatively resistant C57Bl/6 mice 
infected with T. brucei (Hertz et al., 1998) or T. congolense (Magez et al., 2006). Wei and 
Tabel (2008) reported that CD8+ NKT cells have a potential for protection against T. 
congolense infection induced by sub cutaneous injection of trypanosomes, presumably by 
inducing NO, but under normal conditions of infections, the CD8+ NKT cells appear to be 
suppressed by CD4+FoxP3+ Tregs.  
1.2.2.2.3. Role of T cells in the inflammatory response in T. congolense infections 
 The cytokine pattern observed in T. congolense infections does not fit the TH1/TH2 
paradigm since T. congolense-infected BALB/c mice have high serum levels of IFN-γ and IL-
10 (Mosmann and Coffman, 1989).  IFN-γ and IL-10 were produced by matrix-adherent 
spleen cells (Uzonna et al., 1998c). The production of IFN-γ and IL-10 required the absolute 
synergy of the Thy 1.2+ and Thy1.2- cell populations, since neither the Thy 1.2+ cells nor the 
Thy1.2- cells alone produced significant amounts of these cytokines (Uzonna et al., 1998c).  
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The early mortality in infected BALB/c mice occurs due to systemic inflammatory response 
syndrome mediated by IFN-γ produced by MHC class II-restricted CD4+ T cells (Shi et al., 
2003).  Studies with monoclonal antibodies which block IL-10 receptor showed that the 
excessive action of these pathogenic T cells and excessive activation of the macrophages are 
down-regulated in infected C57BL/6 mice via the action of IL-10 (Shi et al., 2003; Shi et al., 
2007). In T. congolense-infected C57BL/6 mice, CD4+CD25+FoxP3+ Tregs producing IL-10 
are required for controlling the excessive activation of macrophages (Guilliams et al., 2007).  
Tabel et al., (2008) discussed the T. congolense infection of mice in relation to dysregulation 
of macrophages and their interaction with T cells with the use of a simplistic diagram (Fig. 
1.5).  
 
 
Fig.1.5. (A). Model for relatively resistant C57BL/6 mouse infected with T. congolense. 
 (Tabel et al., 2008). 
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 T cell-independently produced (Campbell et al., 1978; Pinder et al., 1986) IgM anti-
VSG will bind to the circulating trypanosomes (step 1), activate complement and mediate 
deposition of iC3b (Pan et al., 2006). Macrophages phagocytose the opsonized parasites 
predominantly via macrophage receptor CR3 (step 2) (Pan et al., 2006). Pulsed macrophages 
produce moderate amounts of monokines (step 3) (Kaushik et al., 1999b; Kaushik et al., 
2000). The macrophage will process the engulfed trypanosomes and present trypanosomal 
antigens via MHC class II to the CD4+ T cell (step 4). Activated CD4+ pathogenic T cell will 
produce IFN-γ (step 5), which will induce the macrophage to produce enhanced amounts of 
monokines and NO (step 3) (Kaushik et al., 1999a; Kaushik et al., 2000). The macrophages 
also produce IL-10, which down-regulates the activation produced by IFN-γ in a negative feed 
back loop via an autocrine pathway (step 6). IL-10 has an effect on maturation of 
CD4+CD25+FoxP3+ Tregs (Papiernik, 2001). Tregs will produce IL-10 which down-regulate 
the effects of pathogenic T cells and macrophages (step 7) (Shi et al., 2006a; Guilliams et al., 
2007). Steps 1, 2, 3 and 5 have been well documented. Whether the pathogenic/suppressor T 
cells are specific for one or several different trypanosomal antigens remains to be determined.    
 In trypanosome infections, T lymphocyte proliferation occurs but is decreased with the 
progress of infection (Mayor-Withey et al., 1978). Analysis of VSG-specific antibodies in 
trypanosome infected BALB/c nude (nu/nu) and Thymus intact (nu/+) mice demonstrated that 
in the absence of T cells there is a significant B cell response to the exposed VSG epitopes. 
However, these responses are greatly enhanced in the presence of T cells. Immunization with 
soluble VSG in the absence of infection produced only T cell-dependent responses (Reinitz 
and Mansfield, 1990). VSG-specific CD4+ T helper cells were predominantly found in the 
peritoneal cavities of relatively resistant mice (Schleifer and Mansfield, 1993).   Mice which 
lack B cells, but not T cells, were unable to mount an effective response (Campbell et al., 
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1977). Reduced T and B cell responsiveness has been credited to T cell mediated 
immmunosuppression (Eardley and Jayawardena, 1977; Jayawardena et al., 1978; Pearson et 
al., 1978; Pearson et al., 1979). It has been shown that there are suppressor (Uzonna et al., 
1998c) and pathogenic T cell populations (Shi et al., 2003) in T. congolense-infected BALB/c 
mice. They are the main producers of IFN-γ, which influences the suppression of splenocyte 
proliferation responses to Con A in mice (Uzonna et al., 1998a; Uzonna et al., 1998c). These 
cells are also involved in the suppression of T cell proliferative responses to Con A as well as 
suppression of B cell responses to T cell-dependent antigens in vitro. It seems that these IFN-
γ-producing T cells, that show disease enhancing effects and show suppressor activities, are 
predominantly CD4+  (Uzonna et al., 1998c; Shi et al., 2003) and MHC-II restricted (Shi et al., 
2006a). Although Schofield et al (1999) have shown that immunization with purified 
membrane VSG induces CD1d-restricted NKT cells that facilitate IgG antibody responses, 
CD1d-restricted immune responses do not play an important role in susceptibility and 
resistance of mice infected with T. congolense intraperitoneally (Shi et al., 2006b). In contrast, 
Wei and Tabel (2008) reported that there is an early protective response mediated by CD8+ 
NKT cell dependent activation of macrophages to kill parasites by production of NO in 
susceptible BALB/c mice treated with anti-CD25 antibody prior to subcutaneous infections.    
 1.2.2.3 Cytokines in African trypanosomiasis 
 In murine T. brucei infections, suppression of lymph node T cells results from 
suppression of IL-2 secretion and IL-2 receptor expression (Sileghem et al., 1987; Sileghem et 
al., 1989b; Sileghem and Flynn, 1992). Suppression of IL-2 secretion has been shown to be 
due to production of prostaglandins by suppressor macrophages (Sileghem et al., 1989a) and 
IFN-γ might be actively involved in the inhibition of IL-2 receptor expression (Darji et al., 
1993; Darji et al., 1996). 
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 IFN-γ can play a beneficial or detrimental role in animal trypanosomiasis. The role of 
IFN-γ may depend on certain factors such as virulence of infecting strain, trypanosome species 
and genetic make up of the host. IFN-γ has been claimed to act as a growth factor for T. brucei 
(Olsson et al., 1991). But it has not been possible to demonstrate growth stimulatory effects of 
IFN-γ on T. congolense (Kaushik et al., 1997). T. brucei-infected mice which have disrupted 
IFN-γ genes showed reduced parasitemia and increased survival time (Bakhiet et al., 1996). 
Opposite outcomes were observed in another study (Namangala et al., 2001). However, it has 
also been convincingly shown, using IFN-γ knock-out mice, that IFN-γ is required for the 
survival of relatively resistant C57BL/6 mice infected with T. brucei (Hertz et al., 1998) or T. 
congolense (Magez et al., 2006). IFN-γ-receptor deficient mice were used to show that IFN-γ-
mediated immune activation is crucial for parasitemia control (Magez et al., 2006). In contrast, 
excessive secretion of IFN-γ during T. congolense infections in highly susceptible BALB/c 
mice leads to early mortality (Uzonna et al., 1998c; Shi et al., 2003). Anti-IFN-γ treatment of 
T. congolense-infected susceptible BALB/c mice prevents the early death of the infected mice 
(Uzonna et al., 1998a). IFN-γ plays a dual role in African trypanosomiasis (Tabel et al., 2008) 
by being a requirement for the survival of relatively resistant C57Bl/6 mice infected with T. 
brucei (Hertz et al., 1998) or T. congolense (Magez et al., 2006) and being detrimental by 
mediating the early death of susceptible BALB/c mice infected with T. congolense (Shi et al., 
2003).  
IFN-γ and IL-10 were produced by matrix-adherent spleen cells (Uzonna et al., 1998c). 
The production of IFN-γ as well as IL-10 required the absolute synergy of the Thy 1.2+ and 
Thy 1.2- cell populations, since neither the Thy 1.2+ nor the Thy 1.2- population alone 
produced significant amounts of above cytokines (Uzonna et al., 1998c). Most of the adherent 
spleen cells were mφs which were Thy 1.2-. Deletion experiments and immunocytochemistry 
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showed that a small proportion of the adherent cell population was T cells: Thy 1.2+ CD3+ 
TCRβ+/γδ- and predominantly CD4+ (Uzonna et al., 1998c; Shi et al., 2006a).  
   IL-10 is a known suppressor of the production of other cytokines as well as certain 
regulatory molecules such as NO (Taylor et al., 1998). Cattle infected with T. congolense had 
elevated IL-10 mRNA in their spleen, blood and lymph nodes suggesting that IL-10 might 
have an effect on the apparent failure of bovine monocytes to produce inflammatory 
molecules (Taylor et al., 1998). IL-10 level is found to be increased in both infected tolerant 
N’Dama cattle and susceptible Boran cattle (Naessens, 2000). Higher levels of IL-10 mRNA 
transcripts were detected in the spleens, peripheral blood mononuclear cells and lymph nodes 
of susceptible than in the resistant breeds of cattle infected with T. congolense (Taylor et al., 
1996). It has been suggested that higher levels of IL-10 might be associated with the observed 
higher levels of immunosuppression in susceptible breeds (Taylor, 1998). Plasma of highly 
susceptible BALB/c mice contains significantly higher levels of IL-10 than relatively resistant 
C57BL/6 mice following infection. Highly susceptible BALB/c mice, when treated with anti-
IL-10 antibody during the infection showed a reduction of parasitemia and a moderate 
increase in survival (Uzonna et al., 1998b). Infected resistant C57BL/6 mice, when treated 
with antibodies to the IL-10 receptor (IL-10R) die early suggesting that IL-10 is crucial in 
controlling the detrimental effects mediated by IFN-γ (Shi et al., 2003). When IL-10 function 
is impaired, MHC class II-restricted immune responses mediate early mortality in resistant 
C57BL/6 mice. Therefore, in T. congolense infections, MHC class II-restricted immune 
responses mediated either disease or protection, depending on IL-10 function (Shi et al., 
2007). IL-10 plays a dual role in African trypanosomiasis by exerting a detrimental role in 
mediating immunosuppression (Uzonna et al., 1998b) but being beneficial by controlling 
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excessive production of lethal cytokines by macrophages (Shi et al., 2003; Shi et al., 2006a; 
Guilliams et al., 2007).   
 Tumour necrosis factor (TNF-α) is an inflammatory cytokine which has a wide range 
of biological activities including apoptosis, cytotoxicity, immunomodulation, inflammation 
and cellular proliferation (Aggarwal and Natarajan, 1996). Induction of TNF-α, and the role of 
TNF-α in immunopathology is well documented in African trypanosomiasis (Sileghem et al., 
1994a; Sileghem et al., 1994b). Increased expression of TNF-α in the brains of T. brucei-
infected mice has been documented (Hunter et al., 1991). Continuous release of TNF-α from 
the activated macrophages of infected animals is a characteristic feature in chronic wasting 
disease associated with trypanosomiasis (Beutler and Cerami, 1988). It has been found that 
there is an association between TNF-α production by monocytes and the severity of anemia in 
infected cattle (Sileghem et al., 1994a), trypanosome-elicited immunsuppression and 
morbidity (Magez et al., 1999) and neuropathological symptoms in human sleeping sickness 
(Okomo-Assoumou et al., 1995). Treatment of T. brucei-infected mice with anti-TNF-α 
antibodies showed a significant increase in parasitemia suggesting that TNF-α also is 
important in the control of trypanosomal growth (Magez et al., 1993; Magez et al., 1997).  It 
has been claimed that TNF-α is both trypanolytic and trypanostatic for T. brucei brucei and T. 
brucei rhodesiense in vitro (Lucas et al., 1994). It has been found that the control of T. 
congolense infection depends on macrophage/neutrophil derived soluble TNF and intact TNF 
receptor 1 (TNFp55) signaling, which induces trypanolytic NO (Magez et al., 2007). TNF-α 
plays a dual role in African trypanosomiasis by exerting a detrimental role in 
immunopathology and being beneficial by acting as a regulator of trypanosomal growth 
(Magez et al., 1993; Magez et al., 1997). 
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 Knowledge of the roles of other cytokines in trypanosomiasis is limited. Following 
infections with T. brucei, higher levels of TGF-β and lower levels of TNF-β mRNA was 
detected in spleens of resistant and susceptible mice respectively (Bakhiet et al., 1996). 
During, experimental infection with T. congolense, the induction of costimulatory cytokines 
such as IL-1 and IL-2 were depressed in both susceptible AJ and resistant C57BL/6 mouse 
strains at the early infection (Mitchell et al., 1986).  
1.2.3. Immunomodulation 
1.2.3.1. Polyclonal B cell activation 
 Hypergammaglobulinemia with mainly IgM antibody and marked B cell expansion is 
consistently found in the spleen and lymph nodes in trypanosome infections (Murray et al., 
1974). This elevated serum IgM level is used as a screening test in diagnosing  sleeping 
sickness of humans in endemic areas of sub-Saharan Africa (Cunningham et al., 1967).  
 The increased levels of immunoglobulins consists of antibodies against both 
trypanosome-related and unrelated antigens, including autoantibodies (Hudson et al., 1976). 
Trypanosome-unrelated antibodies produced in T. brucei-infected mice are antibodies to sheep 
red blood cells, pneumococcal polysaccharides and haptens (Hudson et al., 1976; Kobayakawa 
et al., 1979). The above observations led to the suggestion that African trypanosomes possess 
B cell mitogens which cause non-specific activation of B cells (polyclonal activation).  
 It has been demonstrated that the trypanosomal membranes were mitogenic for spleen 
cells of normal athymic and cyclophosphamide-treated mice in vitro (Esuruoso, 1976). Also, 
whole or fractionated homogenates of trypanosomes have been reported to induce polyclonal 
activation of lymphocytes (Mansfield, Craig et al. 1976; Greenwood and Oduloju 1978). It has 
been reported that the purified soluble VSG molecules are mitogenic for B cells (Diffley, 
1983). Mice immunized with purified VSG showed marked enlargement of B cell 
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compartments in the spleen and an increase in serum IgG levels mostly due to the production 
of polyclonal antibodies (Diffley, 1983). The mechanism of the polyclonal B cell activation is, 
however, unknown.  
 It is known that binding of an antigen by the B cell receptor and cross-linking of the 
complement receptor 2 (CR2) simultaneously has a synergistic effect on B cell activation 
(Klaus, 1986; Tedder et al., 1997). A soluble fragment of the VSG of T. congolense forms a 
covalent product with a breakdown component of C3 (VSG-C3b) in the presence of variant 
specific antisera (Liu, 1991; Liu et al., 1993). 
 The membranes of insect stages of trypanosomes which do not possess VSG, do not 
cause polyclonal activation suggesting that bloodstream forms of trypanosomes may induce 
polyclonal B cell activation as an evasion mechanism (Oka et al., 1988). Because the affinity 
maturation does not occur during polyclonal B cell activation, selective proliferation and the 
production of high affinity antibodies against the trypanosomes might be prevented (Roitt, 
1997).  
1.2.3.2. Immune suppression 
 Immunosuppression is a remarkable feature of trypanosomiasis in cattle, mice and 
humans (Roelants and Pinder, 1984; Askonas, 1985; Sileghem et al., 1994b; Taylor, 1998). B 
and T cell responses to trypanosome and non-trypanosome antigens have been suppressed in 
most hosts, with the exception of trypanoresistant wildlife (Mulla and Rickman, 1988). It was 
proposed that the major cause of increased susceptibility of trypanosome-bearing individuals 
to opportunistic infections is generalized immunosuppression observed in patients 
(Greenwood et al., 1973). Infections of cattle with T. congolense and T. vivax cause 
suppression of antibody responses to some vaccines (Rurangirwa et al., 1978; Ilemobade et al., 
1982). Suppressed antibody response to Brucella abortus was observed in sheep infected with 
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T. congolense (Malu and Tabel, 1986). In dogs, infections with T. congolense have been 
shown to suppress antibody response to Brucella abortus vaccine (Anene, 1989). Water 
buffaloes infected with T. evansi had an increased prevalence of brucellosis (Bajyana Songa et 
al., 1987).  
 Suppression of T cell and B cell responses has been studied in laboratory rodent 
models. Various T cell responses are severely affected including allogeneic graft rejection 
(Pearson et al., 1978), mixed lymphocyte reaction (Pearson et al., 1978; Roelants et al., 1979), 
mitogen-induced proliferation (Jayawardena and Waksman, 1977; Morrison et al., 1978; 
Sileghem et al., 1989b) and delayed type hypersensitivity (Mansfield and Wallace, 1974).  
 A progressive depletion or exhaustion of antigen-reactive B cells due to polyclonal 
activation could later result in immunosuppression. Polyclonal activation and 
immunosuppression were induced in vivo by the administration of trypanosome membrane 
fragments (Clayton et al., 1979b; Sacks et al., 1982). It has been suggested that parasite-
unrelated immune responses are depressed in trypanosomiasis while the variant-specific 
immune responses are not affected (Mansfield, 1981) and the recovery of B cell function is 
very rapid after chemotherapy (Clayton et al., 1980). There is evidence that antigen 
nonspecific suppressor cells present in the lymphoid compartments of trypanosome-infected 
animals are involved in immunosuppression  (Corsini et al., 1977; Jayawardena and 
Waksman, 1977; Pearson et al., 1978; Pearson et al., 1979; Roelants et al., 1979; Wellhausen 
and Mansfield, 1979; Pearson et al., 1979a; Roelants et al., 1979b; Askonas, 1985; Schleifer 
and Mansfield, 1993; Sileghem, 1994; Sileghem et al., 1994b). Peritoneal macrophages of  
T. brucei-infected mice were also capable of passively transferring suppression to normal 
spleen cells (Corsini et al., 1977; Clayton et al., 1979a).  
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 Suppression of T cells in lymph nodes in T. brucei-infected mice results from 
suppression of IL-2 secretion and IL-2 receptor expression (Sileghem et al., 1987; Sileghem et 
al., 1989b; Sileghem and Flynn, 1992). Suppression of IL-2 receptor expression was 
associated with endogenously produced IFN-γ (Darji et al., 1993; Darji et al., 1996). It has 
been suggested that IFN-γ acts on macrophages, leading to the release of a soluble factor 
associated with the suppression of lymph node proliferative responses (Darji et al., 1996). 
TNF-α has also been implicated in suppression of lymph node cells in mice infected with T. 
brucei (Lucas et al., 1993; Darji et al., 1996). IL-10 and IFN-γ contributed to the suppression 
of splenocyte proliferative responses to ConA in infected BALB/c mice (Uzonna et al., 1998b; 
Uzonna et al., 1998c), identifying IL-10 and IFN-γ as mediators of immunosuppression. The 
induction of IL-10 and IFN-γ synthesis was trypanosome-specific and required antigen-
presenting cells (Uzonna et al., 1998c).  
 It has been shown that NO mediates suppression of splenic T cell responses in T. 
brucei (Sternberg and McGuigan, 1992; Sternberg and McGuigan, 1994; Mabbott et al., 1995) 
and T. rhodesiense-infected mice (Schleifer and Mansfield, 1993). It has been shown that IL-
10 and IFN-γ but not NO are responsible for the observed immunosuppression in T. 
congolense-infected mice (Uzonna et al., 1998b). Therefore, the role of NO in mediating 
immunosuppression in trypanosomiasis depends upon various factors such as the strain of 
mice and the strain of the parasite as well as the host.  
1.2.3.3. Role of T cells in immunosuppression in African trypanosomiasis 
 General immunosuppression has been known in T. brucei- and T. congolense- infected 
cattle and mice (Hudson et al., 1976; Roelants et al., 1979; Rurangirwa et al., 1979; Askonas, 
1985).  Roelants and Pinder (1984) concluded that immunosuppression might be mediated by 
both the suppressor macrophages and suppressor T cells. IL-10 as well as IFN-γ contributes to 
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the suppression of proliferative responses of the splenocytes to ConA in infected BALB/c 
mice (Uzonna et al., 1998b; Uzonna et al., 1998c). Thy 1.2- adherent spleen cells from 
uninfected mice could provide the suppressive effects only when pulsed with T. congolense 
and coculture with Thy 1.2+ cells obtained from infected mice but not with Thy 1.2+ cells from 
normal mice (Uzonna et al., 1998c).  
1.2.3.4. Regulatory T cells (Tregs) 
 Tregs are a specialized subpopulation of T cells which act to control activation of other 
immune cells and thereby maintain the homeostasis of the immune system, self-tolerance and 
control excessive immune responses to foreign antigens (Le and Chao, 2007).  Regulatory T 
cells first described in 1995, are known to suppress autoimmunity (Fehervari and Sakaguchi, 
2004). They can suppress immune responses to infectious agents and control 
immunopathology (Mills, 2004; Belkaid and Rouse, 2005).  The best described Treg 
population is the natural Tregs which arise during T cell development in the thymus and 
highly express the α chain of the IL-2 receptor (CD25). The other types of Tregs can be 
induced (inducible Tregs) from naïve T cells in the periphery during normal immune 
responses.  
1.2.3.5. Natural T regs 
 Naturally occurring CD4+CD25+ T cells in mice have regulatory functions and 
constitute about 5-10 % of all T helper cells were first described in 1995 (Sakaguchi et al., 
1995). Naturally occurring Tregs are thymus-derived (Sakaguchi et al., 1995). Natural 
CD4+CD25+ Tregs were found to express high levels of transcription factor FoxP3 (Hori et al., 
2003). Natural CD4+CD25+ T cells could not be detected in FoxP3-/- mice (Fontenot et al., 
2003). It is assumed that only a part of CD4+CD25+ T cell population exerts regulatory 
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activity, such as CD4+CD25high cells. Also it is clear that not all T cells that exert suppressive 
activity express CD25 (Beissert et al., 2006).  
 An increased pool of CD4+CD25+ regulatory T cells was found in the peripheral blood 
of cancer patients with potent immunosuppressive features (Wolf et al., 2003). Tregs in the 
tumor sites prevent the development of CD4 helper cells and subsequent development of 
efficient CD8 T cell activity required for the control of tumor growth (Chaput et al., 2007). 
Although natural Tregs require activation with specific antigen to attain their suppressive 
phenotype, once activated they execute inhibition in an antigen specific as well as non-specific 
fashion.  
 Although most studies have investigated the regulatory properties of Tregs and natural 
killer T cells independently of each other, recent reports have provided evidence for cross-talk 
between Tregs and NKT cells. Activated NKT cells seem to modulate Treg function through 
IL-2-dependent mechanisms, whereas Tregs can suppress the proliferation, cytokine release 
and cytotoxic activity of NKT cells by cell-contact-dependent mechanisms (La Cava et al., 
2006). 
 Natural Tregs could control allergic airway inflammation in an IL-10 independent 
manner in a murine model (Leech et al., 2007). Tregs facilitate early protective responses to 
local viral infection by allowing a timely entry of immune cells into infected tissue during 
mucosal herpes simplex virus infection in mice (Lund et al., 2008). In murine models of 
Leishmania infection, following resolution of infection in healed mice, CD25+Foxp3+ Tregs 
function in an IL-10-dependent manner to prevent sterile cure and to establish a long-term 
state of functional immune privilege in the skin (Peters and Sacks, 2006). Further, the majority 
of natural Treg cells at the infected site are Leishmania-specific and parasite-specific natural 
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Treg cells are restricted to sites of infection and that their survival is strictly dependent on 
parasite persistence (Suffia et al., 2006).   
1.2.3.6. Inducible T regs 
 The inducible Tregs are induced from the naïve T cells of the periphery by the 
immunosuppressive cytokine TGF-β (Chen et al., 2003) or by low dose antigenic stimulation 
by peptides (Apostolou and von Boehmer, 2004). Inducible Tregs do not have unique surface 
markers to distinguish them from other T cell subsets (Table 1.2). Also, it is not clear whether 
FoxP3 regulate the development of Th3 or Tr1 cells. However, TGF-β has been shown to 
convert peripheral CD4+CD25- naïve T cells into CD4+CD25+ Tregs, probably through the 
induction of FoxP3 expression (Chen et al., 2003). Unlike natural Tregs, both Th3 or Tr1 are 
inducible Tregs and appear to function independently of cell-cell contact and suppress immune 
responses through the secretion of cytokines such as TGF-β (Josien et al., 1998) and IL-10 
(Groux et al., 1997). 
 It has been shown that activation of human CD4+ T cells with anti-CD3 and anti-CD46 
induced a T-regulatory cell 1 phenotype which produced enhanced amounts of IL-10 (Kemper 
et al., 2003). Thus, cross-linking of Crry or CD46 by antigens coated with complement 
fragments during antigen presentation can modulate the T reg cell response (Kemper et al., 
2005). 
1.2.3.7. Roles of regulatory T cells during infections 
 In Tuberculosis, higher levels of FoxP3 mRNA and slightly lowered expression of IL-
10 was observed in blood of TB patients while a significantly lower FoxP3 mRNA expression 
with no difference in IL-10 expression was observed in recently infected contacts. It is not 
clear whether the Tregs play a beneficial or a harmful effect in tuberculosis (Burl et al., 2007).  
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Table 1.2. Subsets of natural and induced regulatory T cells 
Treg subset  Regulatory 
mechanisms  
Transcription 
factor 
expressed  
Target cells Function  
CD4+CD25+ 
Tregs  
Cell contact-
dependent,  
Cytokines  
(IL-10) ?  
FoxP3  T cells, 
APCs  
Suppression of 
autoimmunity, 
inhibition of allograft 
rejection and of immune 
responses induced by 
microbial infection  
CD4+CD25- 
Tregs  
Mostly by 
cytokines  
FoxP3?  T/B cells, 
APCs  
Suppression of 
autoimmunity  
Tr1 cells  Mediated by 
 IL-10  
FoxP3?  T cells  Suppression of 
autoimmunity  
Th3 cells  Mediated by 
TGF-β  
?  T cells  Suppression of 
autoimmunity  
NK Tregs  IL-4, IL-10, 
TGF-β, 
cytotoxicity  
?  T cells, 
APCs, 
tumor cells  
Elimination of tumors 
and pathogens, 
Suppression of 
autoimmunity  
CD8+ Tregs  Cell contact-
dependent  
FoxP3?  T cells  Suppression of 
autoimmunity, 
regulation of peripheral 
TCR repertoire  
CD8+CD28- 
Tregs  
Induction of 
ILT3/ILT4 in 
dendritic cells  
FoxP3?  Dendritic 
cells/APCs  
Regulation of 
autoimmunity  
 
?Issue uncertain, not yet clear or not yet investigated. Abbreviations: APC, antigen-presenting 
cell; ILT, immunoglobulin transcript; NK Treg, regulatory cells of natural killer T cell 
phenotype; Th3, T helper type 3; Tr1 cell, type 1 regulatory T cell; Treg, regulatory T cell. 
(Adapted from Beissert et al., 2006)  
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The frequency and the absolute count of duodenal mucosal Tregs were highly 
increased in untreated HIV patients but were normal in treated HIV patients. However, in 
peripheral blood of HIV patients, the absolute number of Tregs was not increased, and their 
frequency was only slightly elevated. The high increase in count and frequency of mucosal 
Tregs observed in untreated HIV infection, suggest a significant contribution of Tregs to the 
pathogenesis of HIV disease (Epple et al., 2006).  
The increased proportion of Tregs in aged mice was associated with the spontaneous 
reactivation of chronic Leishmania major infection, likely because Tregs efficiently 
suppressed the production of IFN-γ by effector T cells. In vivo depletion of Tregs in old mice 
attenuated the severity of the disease. Accumulation of functional Tregs in aged hosts could 
therefore play an important role in the frequent reactivation of chronic infections that occurs in 
the elderly (Lages et al., 2008).  
It has been demonstrated in Hepatitis C virus (HCV) infection in chimpanzees that the 
frequency of Foxp3+CD4+CD25+ Tregs and the extent of suppression was as high in 
spontaneously recovered chimpanzees as in persistently infected chimpanzees. Thus, Tregs 
control HCV-specific T cells not only in persistent infection but also after recovery, where 
they may regulate memory T-cell responses by controlling their activation and preventing 
apoptosis (Manigold et al., 2006). In human T-lymphotropic virus type 1 infection, there was a 
strong negative corelation between the frequency of CD4+FoxP3+ Tregs in the circulation and 
the rate of cytotoxic T lymphocyte-mediated lysis of autologous HTLV-1-infected cells ex 
vivo (Toulza et al., 2008). 
1.2.3.8. Impact of pathogens on regulatory T cells 
 Epstein-Barr virus can recruit Tregs to the microenvironment of Hodgkin's lymphoma 
by inducing the expression of chemokine ligand 20 (CCL20) in the tumor cells and, by doing 
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so, prevent immune responses against the virus-infected tumor population (Baumforth et al., 
2008). Functionally active and virus-specific FoxP3+ Tregs are induced in hepatitis C virus 
infection, thereby providing targeted immune regulation in vivo (Ebinuma et al., 2008). 
Suppression assays carried out using Tregs purified from WT and IL-6−/− C57BL/6 mice 
infected with influenza virus (H17) showed that IL-6 induced by influenza virus (H17) limits 
the activity of virus-specific Tregs, thereby facilitating the activity of virus-specific memory 
CD4+ T cells (Longhi et al., 2008). Intrathymic injection of the lentiviral vector resulted in an 
enrichment of hemagglutinin antigen-specific Tregs in peripheral lymphoid organs in mice 
(Marodon et al., 2006). In humans, M. tuberculosis mannose-capped lipoarabinomannan 
(ManLAM) resulted in regulatory T cell expansion, whereas the M. tuberculosis 19-kDa 
protein and heat shock protein 65 had no effect (Garg et al., 2008).  
1.2.3.9. Tregs in trypanosomal infections 
 In relatively resistant C57BL/6 mice infected with T. congolense, Foxp3+ Tregs 
originating from the naturally occurring Treg pool expanded in the spleen and the liver. These 
Tregs produced IL-10 and limited the production of IFN-γ by CD4+ and CD8+ effector T cells 
(Guilliams et al., 2007). Also, Tregs down-regulated classical activation of macrophages 
resulting in reduced TNF-α production. These observations suggest a cardinal role for 
naturally occurring Tregs in the development of a trypanotolerant phenotype during African 
trypanosomiasis (Guilliams et al., 2007).  
 When susceptible BALB/c mice were injected with optimal amounts of a depleting 
mAb specific for CD25 two days prior to the infection, the infected mice did not develop 
parasitemia and eliminated all parasites and showed no signs of disease. There was a 100% 
reduction of CD4+CD25high T cells and a 70% reduction of CD4+CD25+Foxp3+ T cells in the 
spleen 7 days post infection. Administration of L-N6-(1-imminoethyl) lysine, a specific 
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inhibitor of inducible NO synthase or administration of anti-CD8 Ab could reverse the 
protective effect caused by treatment of anti-CD25. Most of the anti-CD25 antibody treated 
CD1d-/- mice developed parasitemia but could control subsequent waves of parasitemia (Wei 
and Tabel, 2008). Further, when treated BALB/c mice with anti-CD25 mAb, there was an 
increase of early cytokine release (at day 5 post infection) and an early elevation (at day 3 post 
infection) of CD8+CD122+ cells in the spleen was detected. Collectively these results suggest 
that in normal trypanosomal infections of BALB/c mice, Tregs prevent the activation of CD8+ 
NKT cells which could activate macrophages to produce trypanocidal NO (Wei and Tabel, 
2008). It has been proposed that there is a cross regulation of NKT cells and 
CD4+CD25highFoxP3+ Tregs in experimental T. congolense infections (Tabel et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
2.0 HYPOTHESIS AND OBJECTIVES 
2.1 Introduction 
Rapid death observed in highly susceptible BALB/c mice infected with virulent strains 
of Trypanosoma congolense or Trypanosoma brucei is due to a systemic inflammatory 
response syndrome (SIRS) (Shi et al. 2003). A small subset of pathogenic, MHC class II-
restricted CD4+ T cells, activated during the course of T. congolense infection, mediates early 
mortality in susceptible BALB/c mice via excessive synthesis of IFN-γ (Shi et al. 2006; 
Uzonna et al. 1998a & c). Since these pathogenic T cells are matrix-adherent (Shi et al. 2006; 
Uzonna et al. 1998c), they can be distinguished from the conventional Th1 cells. There is a 
possibility for this subset of pathogenic CD4+ T cells to be a population of T cells with unique 
surface markers.  
 Both the classical pathway and alternative pathways of complement are activated 
during African trypanosomiasis (Greenwood and Whittle, 1980). Hypocomplementemia is a 
prominent feature of experimental African trypanosomiasis in cattle (Tabel et al., 1980), sheep 
(Malu and Tabel, 1986) and mice (Otesile et al., 1991). During the activation of the 
complement system, the final degradation product of complement protein C3 is complement 
component C3d. The amplification of the alternative pathway of complement and the 
degradation of complement C3b to C3d proceeds faster in BALB/c mice than in C57BL/6 
(Ogunremi et al., 1993).  Complement receptor CR2 is a 145 kD transmembrane protein which 
acts as the receptor for C3d. The expression of CR2 on the cell surface of a subpopulation of 
mouse T cells has been documented (Qian et al., 2005). CR2 is expressed on activated T cells 
in AJ mice (Chen et al., 2005).  
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 T. congolense-infected BALB/c mice have more VSG-containing immune complexes 
in their plasma than infected C57BL/6 mice (Pan & Tabel, unpublished). Most of the immune 
complexes might contain VSG-C3d complexes in T. congolense-infected BALB/c mice. The 
presence of VSG-C3d immune complexes in T. congolense-infected BALB/c mice might play 
an important role in the pathogenesis of the infection: costimulation of CR2+ T cells by VSG-
C3d immune complexes might induce a subpopulation of T cells that express CR2 to produce 
excessive amounts of IFN-γ.  
 
2.2 Hypothesis 
In T. congolense-infected BALB/c mice, most of the IFN-γ-producing CD4+ T cells are 
CR2+ and the numbers of CR2+ T cells increase with progression of infection. 
 
2.3 Objectives 
1. Study the kinetics of CR2+ T cells in T. congolense infections in BALB/c mice 
2.     Test the subpopulations of T cells that produce IFN-γ in experimental  
T. congolense infections in BALB/c mice 
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3.0 KINETICS OF CR2+ T CELLS IN EXPERIMENTAL MURINE T. CONGOLENSE 
INFECTIONS 
3.1. Abstract 
In African trypanosomiasis, the complement system is highly activated, leading to 
covalent complexes of variant surface glycoprotein (VSG) and degradation products of 
complement component C3. The final degradation product of C3 is C3d. Complement receptor 
CR2 is the cell surface receptor for C3d. 
 I investigated the kinetic pattern of T cells (CD3+) expressing CR2 in BALB/c mice 
infected with T. congolense. In the first set of experiments, spleen cells of normal and infected 
BALB/c mice were stained with PE-Cy5anti-CD3, PEanti-CR2 and FITCanti-CD25 at days 3, 4, 5, 
6 and 7 post infection and were analyzed by FACS. Total numbers of spleen cells were 
increased 5-fold with progressive infection. Total numbers of CD3+ cells, CR2+ cells and 
CD25+ cells were increased 4 to 5-fold, 3-fold and 6-fold, respectively, with progressive 
infection. The numbers of CD3+CR2+ cells, CD3+CD25+ cells and CD25+CR2+ cells were 
increased 3-fold, 2 to 3-fold and 3 to 3.5-fold, respectively, with the progression of infection.  
Absolute numbers of B cells (CD19+) showed a 5 to 6 fold increase and the numbers of CR2+ 
B cells showed a 4-fold increase at day 7 post infection. In a second set of experiments spleen 
cells of normal and infected BALB/c mice were stained with FITCanti-CD3 and PEanti-CR2 
antibodies. The pattern of CR2+ cells was similar to the one of the previous study. However, 
the total numbers of CR2+ T cells in the spleen of normal mice was found to be considerably 
less, about 1.5 x 106 (instead of 3 x 106) per spleen. The numbers of CD3+ cells and 
CD3+CR2+ cells showed 5-fold and 7-fold increases, respectively. While the total numbers of 
CR2+ cells (including B cells) showed a 4-fold increase, the mean numbers of CR2 per cell 
showed a 50% reduction with progressive infection.  
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 In summary, the study shows that a small subpopulation of CR2+ T cells progressively 
increases 3 to 7-fold in BALB/c mice infected with T. congolense. 
 
3.2. Introduction  
 In experimental infections with African trypanosomes, T lymphocyte proliferation 
occurs but is decreased with the progress of infection (Mayor-Withey et al., 1978). Analysis of 
VSG-specific antibodies in trypanosome-infected nude (nu/nu) BALB/c and thymus intact 
(nu/+) mice showed that in nude mice there is a significant B cell response to the exposed 
VSG epitopes, indicating that most of the early antibody response to VSG is T cell- 
independent (Campbell et al., 1978). In T. congolense-infected BALB/c mice, there is a 
relatively small subpopulation of T cells that have an immunosuppressive (Uzonna et al., 
1998c) and a general pathogenic (Shi et al., 2003; Shi et al., 2006a) function. They are the 
main producers of IFN-γ (Uzonna et al., 1998a; Uzonna et al., 1998c). It seems that these IFN-
γ-producing T cells, that show disease enhancing effects and suppressor activities, are 
predominantly CD4+ (Uzonna et al., 1998c; Shi et al., 2003) and MHC-II-restricted (Shi et al., 
2006a). This subpopulation of T cells differs from the majority of Th1 cells in that they are 
matrix-adherent (Uzonna et al. 1998c; Shi et al. 2006). 
 In mice, CR2 is predominantly expressed on B cells, follicular dendritic cells and 
activated granulocytes. Mouse CR2 is highly expressed on peritoneal and splenic B-1 B 
lymphocytes (Kinoshita et al., 1988; Carroll, 1998). It is known that binding of an antigen by 
the B cell receptor and cross-linking of the complement receptor 2 (CR2) simultaneously has a 
synergistic effect on B cell activation (Klaus, 1986; Tedder et al., 1997). In T cells, CR2 may 
act either as an activating receptor or as an adhesion molecule to promote the recruitment or 
retention of tissue-infiltrating cells (Holers, 2005). Kaya et al. (2001) have provided evidence 
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that CR2+ T cells participate in the development of experimental autoimmune myocarditis. 
CR2 has been found to be expressed on activated T cells in A/J mice (Chen et al., 2005). CR2 
was detectable on both CD4+ and CD8+ subsets of T cells (Kaya et al., 2005). 
Although not investigated, the complexes of cleavage products of complement 
component C3 (C3b, iC3b and C3d) and soluble or particulate trypanosomal antigens might 
have a profound effect upon binding to cells bearing receptors for C3b, iC3b and/or C3d 
(Tabel et al., 2000). T. congolense-infected BALB/c mice have more immune complexes 
containing trypanosomal variant surface glycoprotein than infected C57BL/6 mice (Pan  & 
Tabel, unpublished data).  The degradation of C3b to C3d is very fast in BALB/c mice 
(Ogunremi et al. 1993). We speculate that the majority of the immune complexes in T. 
congolense-infected BALB/c mice might be VSG-C3d immune complexes and that binding of 
these complexes to CR2+ T cells might costimulate these T cells to produce IFN-γ.  
Experiments discussed in this chapter describe the kinetics of CR2+ T cells and B cells 
in the spleen of T. congolense-infected BALB/c mice.  
3.3. Materials and Methods 
3.3.1. Mice 
Female BALB/c mice and CD1 mice were obtained from the Animal Resource Center of the 
University of Saskatchewan. BALB/c mice were 8 to 10 weeks old and CD1 mice were 6 
weeks old. All mice were maintained according to the recommendations of the Canadian 
Council of Animal Care.  
3.3.2. Parasites 
T. congolense, variant antigenic type (VAT) TC13 (Tabel, 1982) was used in this experiment. 
TC13 was passaged in immunosuppressed CD1 mice as described (Tabel, 1982). The parasites 
for the infection of BALB/c mice were obtained by isolating the parasites from the blood of 
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infected CD1 mice using DEAE-cellulose chromatography columns as described (Lanham and 
Godfrey, 1970).  
3.3.3. Antibodies 
The following principle antibodies were used to stain the spleen cells for FACS analysis: PE-Cy5 
Armenian hamster anti-mouse CD3 (BD Pharmingen), PE rat anti-mouse CR2 (eBioscience),  
FITC Rat anti-mouse CD25 (eBioscience), FITC rat anti-mouse CD19 (eBioscience), and FITC 
hamster anti-mouse CD3 (Cedarlane Laboratories). The following antibodies were used as 
isotype control antibodies: PECy5 Armenian hamster IgG (eBioscience), PErat IgG2a 
(eBioscience), FITC rat IgG1 (eBioscience), , FITCmouse IgA (eBioscience) and FITC hamster 
IgG (eBioscience).  
3.3.4. Experimental design 
BALB/c mice were infected intraperitoneally with 103 organisms of trypanosomes. Four 
normal BALB/c mice and four infected BALB/c mice were euthanized each day using CO2 
and single cell suspensions were prepared from the collected spleens at days 3, 4, 5, 6, 7 and 8 
post infection. Red blood cells were lysed using ACK lysing buffer as described (Coico, 
2005). Spleen cells were resuspended at 107 cells/ml in FACS buffer to use these cells for 
staining and FACS analysis.   
3.3.5. Estimation of parasitemia 
To estimate the circulating parasite numbers, a drop of blood from the tail vein of each mouse 
was examined at 400x magnification by phase contrast microscopy. Parasitemia was estimated 
by counting the number of parasites present in 20 fields at the early infection. Heavy parasite 
loads were quantified according to Herbert and Lumsden (Herbert and Lumsden, 1976).   
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3.3.6. FACS analysis 
One hundred micro liter aliquots of 107 cells/ml in FACS buffer were incubated for 10 
minutes on ice with 4 μl of rat anti-mouse CD16/32 (Fcγ II/III receptor, Fc Block, 
eBioscience) monoclonal antibody. Appropriate volumes of each antibody specific for a 
particular cell surface marker were added and incubated on ice in the dark for 30 minutes. The 
cells were washed 2 times with FACS buffer and resuspended in FACS buffer containing 1% 
formalin. Fixed cells were analyzed using a FACScan flow cytometer using Flowjo software 
(Tree Star Inc.).   
3.3.7. Statistical analysis 
 Multiple comparisons were performed by one way analysis of variance (ANOVA) 
using SPSS software. Differences between infected groups and respective normal groups were 
tested by paired T test. A statistical probability of P < 0.05 was considered statistically 
significant. 
 
3.4. Results 
3.4.1. Kinetics of T and B cells in the spleen of infected BALB/c mice 
3.4.1.1. Parasitemia and total numbers of spleen cells 
 Infected mice did not have any visible parasites up to day 4 following infection. 
Parasites started to appear in blood at day 5 post infection and this was followed by an 
increase of parasitemia up to day 7 until the experiment was terminated (Fig.3.1.A). The 
parasitemia pattern was similar in all kinetic studies performed.  
 Total number of spleen cells in normal mice was about 108 in all cases. This number 
showed a 3-fold increase at day 5 post infection and up to 5-fold increases were observed at 
day 7 post infection (Fig.3.1.B).  
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Fig. 3.1. Parasitemia (A) and total number of spleen cells (B) of BALB/c mice infected 
intraperitoneally with 103 T. congolense. (The data shown are representative of mean±SE of 
four similar experiments, n= 4). * P < 0.05 between infected group and respective control 
group. 
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3.4.1.2. Kinetics of CD3+ cells, CR2+ cells, and CD25+ cells in the spleen  
In the results of these experiments, absolute and relative numbers of each cell 
population are presented. The relative number of a particular cell population is presented as 
the percentage of the total spleen cell population. The total numbers of spleen cells increase 
with progress of the infection. Since the dynamics of a subpopulation may change at a 
different rate than that of the total spleen cell numbers, the profile of relative numbers from 
day 0 to day 8 might be quite different from the profile of the absolute numbers.  
Absolute numbers of T cells showed a 4 to 5-fold increase with progressive infection 
(Fig.3.2.A) while the relative numbers of T cells were lower than in normal mice at early 
infection, but increased up to day 7 post infection (Fig.3.2.B).  
There was a 2 to 3-fold increase in absolute numbers of CR2+ cells in the spleen of 
BALB/c mice during the infection (Fig.3.3.A) while the relative numbers showed a decline at 
days 5, 6 and 7 post infection (Fig.3.3.B). It is known that the majority of CR2+ cells in the 
spleen are B cells and follicular dendritic cells (Carroll, 1998). 
 There was a progressive increase in the absolute numbers of CD25+ cells in the spleen 
of infected BALB/c mice which reached a 6-fold increase at day 7 post infection compared to 
those of normal mice (Fig.3.4.A) while the relative numbers showed a 2-fold increase at day 7 
post infection (Fig.3.4.B).  This population of cells would include activated T cells and Tregs. 
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Fig.3.2. Absolute numbers of CD3+ cells (A) and the relative numbers of CD3+ cells (B) in the 
spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 compared to those 
of normal BALB/c mice. PECy5anti-CD3 antibody was used to stain the spleen cells. Values 
represent mean±SE, n= 4. (The data shown are representative of four similar experiments). * P 
< 0.05 between infected group and respective control group. 
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Fig.3.3. Absolute numbers of CR2+ cells (A) and the relative numbers of CR2+ cells (B), in 
the spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 compared to 
those of normal BALB/c mice. PEanti-CR2 antibody was used to stain the spleen cells. Values 
represent mean±SE, n= 4. (The data shown are representative of four similar experiments). * P 
< 0.05 between infected group and respective control group. 
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Fig.3.4. Absolute numbers of CD25+ cells (A) and the relative numbers of CD25+ cells (B), in 
the spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 compared to 
those of normal BALB/c mice. FITCanti-CD25 antibody was used to stain the spleen cells. 
Values represent mean±SE, n= 4. (The data shown are representative of four similar 
experiments). * P < 0.05 between infected group and respective control group. 
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3.4.1.3. CD3+CR2+ cells in the spleen of normal BALB/c and C57BL/6 mice 
 The kinetics of complement activation in highly susceptible BALB/c mice is different 
from that of relatively resistant C57BL/6 mice. The degradation of C3b to C3d during the 
amplification of the alternative pathway of complement proceeds faster in BALB/c than in 
C57BL/6 (Ogunremi et al., 1993). Therefore we speculated that the expression of CR2, the 
receptor for C3d, in T cells might be different between the susceptible and resistant mice. 
Spleen cells of normal BALB/c and C57BL/6 mice were stained for CD3 and CR2 to find out 
whether the numbers of CR2+ T cells show a difference between the two strains of mice. There 
was no significant difference between the numbers of CR2+ T cells in normal BALB/c and 
C57BL/6 mice according to the results (Fig.3.5) obtained by FACS analysis.  
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Fig.3.5. Absolute numbers of CD3+CR2+ cells in the spleen of susceptible BALB/c mice and 
relatively resistant C57BL/6 mice. The cells were stained with PECy5 Armenian hamster anti-
mouse CD3 and PE rat anti-mouse CR2 and analyzed by FACS. (Values represent mean±SE, 
n= 8).  
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3.4.1.4. Kinetics of CD3+CR2+ cells in the spleen 
 The absolute numbers of CD3+CR2+ cells (CR2+ T cells) in the spleen of a normal 
BALB/c mouse was around 3 x 106, when the cells were stained with PECy5 Armenian hamster 
anti-mouse CD3 and PE rat anti-mouse CR2 and analyzed by FACS.  There was no increase in 
the number of CD3+CR2+ cells up to day 3 post infection, but there was a 3-fold increase 
achieved at day 5 and remained at that level until the experiment was terminated at day 7 post 
infection (Fig.3.6.A).  The relative numbers of CD3+CR2+ cells did not show much difference 
at early infection but showed a slight decrease at day 6 and 7 post infection (Fig.3.6.B). The 
original FACS pictures of representative normal and infected spleen cells of BALB/c mice, 
collected at day 6 post infection, are shown in Fig. 3.7. 
3.4.1.5. Kinetics of CD3+CD25+ cells and CD25+CR2+ cells in the spleen 
 Absolute numbers of CD3+CD25+ T cells showed a 2 to 3-fold increase at day 5, 
followed by a 10-fold increase at day 7 post infection (Fig.3.8.A), indicating a progressive 
proliferation of CD25+ T cells during the infection. Relative numbers of CD3+CD25+ T cells 
also increased with progressive infection (Fig.3.8.B). The original FACS pictures of 
representative normal and infected spleen cells of BALB/c mice, collected at day 7 post 
infection, are shown in Fig. 3.9. 
 Absolute numbers of CD25+CR2+ cells showed a 3 to 3.5-fold increase at day 7 post 
infection compared to the normal mice (Fig.3.10.A) but the relative numbers of CD25+CR2+ 
cells remained fairly constant at about 1% during the infection (Fig.3.10.B). The original 
FACS pictures of representative normal and infected spleen cells of BALB/c mice, collected at 
day 7 post infection, are shown in Fig. 3.11. 
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Fig.3.6. Absolute numbers of CD3+CR2+ cells in the spleen (A) and relative numbers of 
CD3+CR2+ cells (B) in the spleen of BALB /c mice infected with 103 organisms of T. 
congolense TC13. The spleen cells were stained with PECy5 Armenian hamster anti-mouse CD3 
and PE rat anti-mouse CR2 and analyzed by FACS.  (Mean±SE values of four experiments.)  
*P < 0.05 between control group and infected groups. 
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Fig.3.7. FACS analysis to detect CD3+CR2+ cells in the spleen. Spleen cells collected from 
normal BALB/c mice and T. congolense-infected BALB/c mice at day 6 post infection were 
stained with PECy5anti-CD3, PEanti-CR2 and isotype control antibodies and analyzed by FACS.  
A: isotype control of normal BALB/c spleen cells, B: normal BALB/c spleen cells stained 
with PECy5anti-CD3 and PEanti-CR2, C: isotype control of infected BALB/c spleen cells 
collected at day 6 post infection, D: spleen cells collected at day 6 post infection stained with 
PECy5anti-CD3 and PEanti-CR2.  
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Fig. 3.8. Absolute numbers of CD3+CD25+ cells (A) and  relative numbers of CD3+CD25+ 
cells (B) in the spleens of BALB/c mice infected intraperitoneally with 103 organisms of T. 
congolense TC13 compared to those of normal BALB/c mice. The spleen cells were stained 
with FITCanti-CD25 and PECy5anti-CD3 antibodies and analyzed by FACS. Values represent 
mean±SE, n= 4. (The data shown are representative of four similar experiments). * P < 0.05 
between infected group and respective control group. 
72 
 
  
 
Fig.3.9. FACS analysis to detect CD3+CD25+ cells in the spleen. Spleen cells collected from 
normal BALB/c mice and T. congolense-infected BALB/c mice at day 7 post infection were 
stained with PECy5anti-CD3, FITCanti-CD25 and isotype control antibodies and analyzed by 
FACS. A: isotype control of normal BALB/c spleen cells, B: normal BALB/c spleen cells 
stained with PECy5anti-CD3 and FITCanti-CD25, C: isotype control of infected BALB/c spleen 
cells collected at day 7 post infection, D: spleen cells collected at day 7 post infection stained 
with PECy5anti-CD3 and FITCanti-CD25.  
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Fig. 3.10. Absolute numbers of CD25+CR2+ cells (A) and  relative numbers of CD25+CR2+ 
cells (B) in the spleens of BALB/c mice infected intraperitoneally with 103 organisms of T. 
congolense TC13 compared to those of normal BALB/c mice. The spleen cells were stained 
with FITCanti-CD25 and PEanti-CR2 antibodies and analyzed by FACS. Values represent 
mean±SE, n= 4. (The data shown are representative of four similar experiments). * P < 0.05 
between infected group and respective control group. 
74 
 
 Fig.3.11. FACS analysis to detect CD25+ CR2+cells in the spleen. Spleen cells collected 
from normal BALB/c mice and T. congolense-infected BALB/c mice at day 7 post infection 
were stained with PEanti-CR2, FITCanti-CD25 and isotype control antibodies and analyzed by 
FACS. A: isotype control of normal BALB/c spleen cells, B: normal BALB/c spleen cells 
stained with PEanti-CR2 and FITCanti-CD25, C: isotype control of infected BALB/c spleen cells 
collected at day 7 post infection, D: spleen cells collected at day 7 post infection stained with 
PEanti-CR2 and FITCanti-CD25.  
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3.4.1.6. Mean intensity of CR2 in the spleen cells during T. congolense infections 
 In these kinetic studies, the mean expression of numbers of CR2 per cell decreased 
with the progressive T. congolense infection in BALB/c mice (Fig. 3.12). It is conceivable that 
continued binding and endocytosis of VSG-C3d complexes might lead to a decrease of CR2+ 
intensity in B cells with the progressive infection.  
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Fig.3.12. Mean intensity ± SE of CR2 on all CR2+ cells in the spleen cells of normal and T. 
congolense-infected BALB/c mice.  PEanti-CR2 antibody was used to stain the spleen cells. 
The fluorescent intensity of the spleen cells were measured by FACS. Values represent 
mean±SE, n= 4. (The data shown are representative of three similar experiments). * P < 0.05 
between infected group and respective control group. 
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3.4.1.7. Kinetics of CD19+ cells and CD19+CR2+ cells in the spleen 
 B cells express CD19 and most of the B cells express CR2 while the expression of 
CR2 in T cells is limited to a small subpopulation of T cells. Therefore it is worthwhile to find 
out the kinetics of CR2+ B cells in T. congolense-infected BALB/c mice in parallel to the 
kinetics of CR2+ T cells. In order to find out the kinetics of B cells and CR2-expressing B 
cells, spleen cells of normal and infected mice were stained for CD19 and CR2.  
 Absolute numbers of B cells showed a 5 to 6-fold increase by day 7 post infection 
(Fig.3.13.A) indicating enhanced B cell proliferation or decreased apoptosis. The relative 
numbers of B cells remained similar to that of normal BALB/c mice throughout the 
experimental period (Fig.3.13.B), There was a 4-fold increase in the absolute numbers of 
CR2+ B cells at day 7 post infection compared to the numbers in normal spleen (Fig.3.14.A). 
Relative numbers of CR2+ B cells did not change significantly throughout the experimental 
period (Fig.3.14.B). 
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Fig. 3.13. Absolute numbers of CD19+ cells (A) and relative numbers of CD19+ cells (B), in 
the spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 compared to 
those of  normal BALB/c mice. The spleen cells stained with FITCanti-CD19 were analyzed by 
FACS. Values represent mean±SE, n= 4. (The data shown are representative of two similar 
experiments). * P < 0.05 between infected group and respective control group. 
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Fig. 3.14. Absolute numbers of CD19+CR2+ cells (A) and relative numbers of CD19+CR2+ 
cells (B) in the spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 
compared to those of  normal BALB/c mice. The spleen cells were stained with  FITCanti-CD19 
and PEanti-CR2 antibodies and analyzed by FACS. Values represent mean±SE, n= 4. (The data 
shown are representative of two similar experiments). * P < 0.05 between infected group and 
respective control group. 
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3.4.1.8. Preliminary discussion of the first set of experiments: technical problems 
In the first set of kinetic studies FITCanti-CD25, PEanti-CR2 and PECy5anti-CD3 were 
used to stain spleen cells for FACS analysis. FACS analysis of the spleen cells stained with 
PECy5 anti-CD3 antibody indicated a right shift of the negative cell population stained with a 
PE antibody specific for an unrelated antigen.  The use of PEanti-CR2 and PECy5anti-CD3 in the 
(triple stain) kinetic study was unsatisfactory, because there is a problem with an overlap of 
PE and PECy5 stains in analysis of FACS (Fig.3.20). These technical problems might affect 
the results especially when working with very low numbers of cells, i.e. less than 2% of total 
cells. Thus, spleen cells stained with PECy5anti-CD3 and PEanti-CR2 yield higher numbers of 
CD3+CR2+ cells, as detected by FACS analysis, than spleen cells stained with FITCanti-CD3 
and PEanti-CR2. We had not been aware of this problem before. This was the reason for 
carrying out the second set of kinetic study in normal and infected BALB/c mice using 
FITCanti-CD3 and PEanti-CR2 antibodies and suitable isotype control antibodies.   
 
 
 A                               B                           C                             D                             E
 
Fig.3.15. Histograms showing PECy5 intensity of unstained spleen cells (A) and the spleen 
cells stained with PE anti-CR2 (B), isotype control antibodies for PECy5 and PE (C),  PECy5anti-
CD3 (D), and spleen cells stained with PEanti-CR2 and PECy5anti-CD3 (E) as detected by FACS 
analysis. Spleen cells were obtained from normal BALB/c mice. 
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3.4.2. Kinetics of CD3+CR2+ cells in the spleen using a different set of antibodies 
 In a second set of experiments spleen cells of normal and infected BALB/c mice at 
days 3, 5, 6, 7 and 8 post infection were stained with FITCanti-CD3 and PEanti-CR2 antibodies.  
 
3.4.2.1. Parasitemia and total numbers of spleen cells 
 Parasitemia and the total numbers of spleen cells showed a similar pattern as observed 
in previous kinetics experiments described in Fig.3.1. Infected mice did not have any visible 
parasites up to day 4 following infection. Parasites started to appear in blood at day 5 post 
infection and this was followed by an increase of parasitemia up to day 8 when the experiment 
was terminated (Fig.3.16).  
 Total number of spleen cells in normal mice was about 108 in all cases. The number of 
spleen cells showed a 3-fold increase at day 5 post infection and an up to 5-fold increase has 
been observed at day 7 and 8 post infection (Fig.3.16). This increase might be due to the 
proliferation of different cell types of the spleen as a response to the ongoing infection.  
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Fig. 3.16. Parasitemia (A) and total number of spleen cells (B) of BALB/c mice infected 
intraperitoneally with 103 T. congolense organisms. Values represent mean±SE, n= 4. (The 
data shown are from a single experiment). * P < 0.05 between infected group and respective 
control group. 
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3.4.2.2. Kinetics of CD3+ cells and CD3+CR2+ cells in the spleen 
The absolute numbers of CD3+ cells showed a 5-fold increase with progressive infection (Fig. 
3.17.A). Relative numbers of CD3+ cells decreased at day 3 and 5 and then came back to 
normal at day 6, 7 and 8 post infection (Fig.3.17.B). The absolute numbers of CD3+CR2+ cells 
increased with the infection up to 7-fold (Fig.3.18.A). There was an increase of relative 
numbers of CD3+CR2+ cells at day 7 and 8 post infection, resulting in a 2-fold increase at day 
8 (Fig. 3.18.B). The original FACS pictures of representative normal and infected spleen cells 
of BALB/c mice, collected at day 8 post infection, are shown in Fig. 3.19. 
 
3.4.2.3. Kinetics of CR2+ cells in the spleen 
The numbers of all CR2+ cells showed an increase up to day 6 and then showed a 
slight decrease at day 7 and 8 (Fig.3.20.A) while the relative numbers of CR2+ cells decreased 
with the progression of infection (Fig.3.20.B).  There was a significantly reduced mean 
expression of numbers of CR2 per cell in all CR2+ cell population with progression of the 
infection (Fig.3.20. C, D & E).  
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Fig. 3.17. Absolute numbers of CD3+ cells (A) and relative numbers of CD3+ cells (B) in the 
spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 compared to those 
of normal BALB/c mice. The spleen cells were stained with FITCanti-CD3 and analyzed by 
FACS. Values represent mean±SE, n= 4. (The data shown are from a single experiment). * P < 
0.05 between infected group and respective control group. 
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Fig. 3.18. Absolute numbers of CD3+CR2+ cells (A) and relative numbers of CD3+CR2+ cells 
(B) in the spleen of BALB/c mice infected with 103 organisms of T. congolense TC13 
compared to those of normal BALB/c mice. The spleen cells were stained with  FITCanti-CD3 
and PEanti-CR2 antibodies and analyzed by FACS. Values represent mean±SE, n= 4. (The data 
shown are from a single experiment). * P < 0.05 between infected group and respective 
control group. 
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Fig.3.19. FACS analysis to detect CD3+CR2+ cells in the spleen. Spleen cells collected from 
normal BALB/c mice and T. congolense-infected BALB/c mice at day 8 post infection were 
stained with PEanti-CR2, FITCanti-CD3 and isotype control antibodies and analyzed by FACS. 
A: isotype control of normal BALB/c spleen cells, B: normal BALB/c spleen cells stained 
with PEanti-CR2 and FITCanti-CD3, C: isotype control of infected BALB/c spleen cells 
collected at day 8 post infection, D: spleen cells collected at day 8 post infection stained with 
PEanti-CR2 and FITCanti-CD3.  
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Fig.3.20. Absolute numbers of CR2+ cells (A) and relative numbers of total CR2+ cells (B).  
Mean intensity ± SE of CR2 in the splenic CR2+ cell population of normal and T. congolense-
infected BALB/c mice (C) and histograms of PE intensity of CR2+ cell population of normal 
(D) and T. congolense-infected BALB/c mice at day 8 post infection (E). Values represent 
mean±SE, n= 4. (The data shown are from a single experiment). * P < 0.05 between infected 
group and respective control group. 
 
87 
 
3.5. Discussion 
 The patterns of parasitemia were similar in both kinetic studies, whether triple staining 
or double staining were used (Fig.3.1 & 3.16), indicating that the levels of infections were 
similar throughout the experiments. Similar increases in numbers of total spleen cells (Fig.3.1 
& 3.16) further suggest that the status of infections was fairly consistent throughout these 
kinetic studies. The observed increase in total numbers of spleen cells could mean increased 
proliferation and/or decreased apoptosis and/or increased influx but decreased outflow of the 
cells.  
 Even though CR2 is predominantly expressed on B cells, follicular dendritic cells and 
activated granulocytes (Carrol, 1998), there are only few reports about the presence of CR2 on 
murine T cells. The results of these experiments showed that there are CR2+ T cells present in 
normal BALB/c and C57BL/6 mice (Fig.3.5) and the numbers of these cells increased in T. 
congolense infections (Fig.3.6 & 3.18). But the available data are insufficient to make 
comments on the possible role of CR2 in T cells in T. congolense infections of mice.  
 Absolute numbers of CD25+ T cells showed a 2 to 3-fold increase at day 5, followed 
by a 10-fold increase at day 7 post infection (Fig.3.8). These CD25+ T cells may contain 
activated T cells and/or T regulatory cells. To confirm this it would be necessary to include an 
additional stain to detect FoxP3, a marker of Tregs which is not expressed on activated T 
helper cells.  
The majority of CR2+ cells would be B cells while only a few of them are T cells 
(Kaya et al., 2005). CD25+ CR2+ cells could be either CD25+ CR2+ T cells or CD25+ CR2+ B 
cells and these two cell types cannot be distinguished without additional markers. Therefore it 
is not possible to come to any conclusions about these CD25+ CR2+ cells except that they 
increase in numbers in T. congolense infections of mice.  
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There was an increase in absolute numbers of CR2+ cells up to day 5 followed by a 
slight decrease as observed in these kinetic studies (Fig.3.3 & 3.20). According to the results 
of these experiments, the numbers of both CR2+ T cells and B cells increased with the 
progression of infection. Spleen remodeling during T. brucei- infection in mice, results in the 
rapid loss of IgM+ marginal zone B cell population characterized as B220+IgMhighIgDint 
CR2highCD23lowCD1d+CD138- (Radwanska et al., 2008). This trypanosomiasis-induced B cell 
apoptosis could be common to T. congolense-infections. Continued binding and endocytosis 
of VSG-C3d complexes might lead to a decrease of CR2+ intensity in B cells with progressive 
infection (Fig. 3.12 & 3.20).  
 IFN-γ producing T cells play an important role in enhancing the immunopathology in 
African trypanosomiasis. Whereas IL-10-producing T cells dampen the excessive activation of 
macrophages (Tabel et al., 2008).  
 There is now good evidence that the numbers of CR2+ T cells significantly increase 
with progression of infection by T. congolense. Whether the presence of CR2+ T cells can be 
causatively linked to the capacity to produce IFN-γ remains to be established.  
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4.0. GENERAL DISCUSSION 
 The primary goals of the present thesis work were to find out the kinetics of CR2 
expressing T cells and the role of these CR2+ T cells in experimental murine T. congolense 
infections. This study has shown that total numbers of CR2+ T cells increase in the spleen of 
T. congolense-infected BALB/c mice with progressive infection (Fig.3.6 & 3.14). 
 Splenomegaly observed in murine trypanosomiasis is a result of proliferation of 
T and/or B cells and also could be due to reduced apoptosis. Proliferation of “null cells” in the 
spleen could also contribute to the observed splenomegaly (Roelants, 1982). Lymphocytic 
hyperplasia in T. musculi infections was observed only in immunologically intact mice but not 
in nude mice indicating that splenomegaly in murine trypanosomiasis is T cell dependent 
(Robinett and Rank, 1979). The present study showed that there is an increase of the total 
number of spleen cells with progressive T. congolense infections in BALB/c mice (Fig. 3.1 
and Fig. 3.12). This observed increase of spleen cell number might be due to the proliferation 
of lymphocytes or due to the reduction of apoptosis of cells. It might also be due to increased 
cell influx to the spleen or reduced outflow from the spleen.  
 CR2 in mice is predominantly expressed on B cells, follicular dendritic cells and 
activated granulocytes(Carrol, 1998). Expression of CR2 on mouse T cells has also been 
documented. CR2 has been detected on subsets of activated T cells (Kaya et al., 2001; Chen et 
al., 2005). The presence of CR2 in CD25+ cells and the increase of CD25+CR2+ cells with the 
progressive infection (Fig.3.8) suggest that there is an increased expression of CR2 in 
activated lymphocytes in the spleen of T. congolense-infected BALB/c mice. CR2 was also 
detectable on both CD4+ and CD8+ subsets of T cells (Kaya et al., 2005). Mesenteric lymph 
nodes of wildtype C57BL/6 mice contain about 4.5% CD4+CR2+ cells (Molnar et al., 2008). 
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Expression of CR2 on splenic T cells of normal or T. congolense-infected BALB/c mice has 
been unknown.  
 The present study showed that uninfected susceptible BALB/c mice and relatively 
resistant C57BL/6 mice express CR2 on subsets of T cells in the spleen (Fig.3.5). The kinetics 
of complement activation is different in highly susceptible BALB/c and relatively resistant 
C57BL/6 mice. The degradation of C3b to C3d during the amplification of the alternative 
pathway of complement proceeds faster in BALB/c than in C57BL/6 mice (Ogunremi et al., 
1993). This would result in more VSG-C3d immune complexes to be present in BALB/c mice 
than in C57BL/6 mice. The present study showed that there is no difference in the numbers of 
CR2+ T cells between normal BALB/c and normal C57BL/6 mice (Fig.3.5). Whether the 
numbers of CR2+ T cells differ in T. congolense-infected BALB/c and C57BL/6 mice has not 
been tested in the present study.  
 An increase in the numbers of CR2+ T cells in the spleen of T. congolense-infected 
BALB/c mice has been observed in the present kinetic studies. The total numbers of CR2+ 
cells increase up to day 6 post infection followed by a decline at day 7 and 8 post infection 
(Fig.3.3 and Fig.3.20). Most of these CR2+ cells might be B cells. The numbers of both CD19+ 
B cells and CR2+ B cells increase with the progressive infection indicating proliferation of B 
cells.  
 Interestingly, the expression of CR2 molecules per cell showed a reduction with 
progressive T. congolense infection in BALB/c mice (Fig. 3.9 and Fig.3.20). There is evidence 
that spleen remodeling during T. brucei-infections in mice results in the rapid loss of IgM+ 
marginal zone B cell population characterized as B220+IgMhighIgDint 
CR2highCD23lowCD1d+CD138- (Radwanska et al., 2008). We suggest that enhanced B cell 
apoptosis, observed in T. brucei infections, might also occur in T. congolense infections. 
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Continued binding and endocytosis of VSG-C3d complexes might lead to a decrease of CR2 
intensity in B cells with progressive infection.  
 In conclusion, the results of the present study showed that the total numbers of CR2+ T 
cells in the spleen increase with progressive T. congolense infections in susceptible BALB/c 
mice. Analysis of spleen cells from T. congolense-infected BALB/c mice for CR2 and intra 
cellular IFN-γ would indicate whether the IFN-γ producing cells express CR2. CR2 in T cells 
might play a role in the pathogenesis of T. congolense infections. Further studies are necessary 
to find out the potential role of CR2+ T cells in T. congolense infections in susceptible 
BALB/c mice.  
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5.0. CONCLUSION  
The major objectives of the present work were to find out the kinetics of CR2 
expressing T cells and the role of these CR2+ T cells in experimental murine T. congolense 
infections.  
The present study showed that both uninfected BALB/c mice and uninfected C57BL/6 
mice express CR2 on subsets of the splenic T cells. The total numbers of CR2+ T cells in the 
spleen of T. congolense-infected BALB/c mice increased with progressive infection. Total 
numbers CR2+ B cells also increased in the spleen of T. congolense-infected BALB/c mice 
with progressive infection.   
 The mean numbers of CR2 molecules per cell in CR2+ cell population of the spleen 
significantly declined with progressive T. congolense infection in BALB/c mice. 
Overall, the results of the present study showed that total numbers of CR2+ T cells in 
the spleen increase with progressive T. congolense infections in susceptible BALB/c mice. But 
whether they require cross-linking of CR2 by complement C3d as a costimulation for the 
production of maximal amounts of IFN-γ is not addressed in the present study. Further studies 
are necessary to find out the potential role of CR2+ T cells in T. congolense infections in 
susceptible BALB/c mice.  
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7.0. APPENDIX: SUBPOPULATIONS OF T CELLS PRODUCING IFN-γ AND/OR  
IL-10 IN EXPERIMENTAL TRYPANOSOMA CONGOLENSE INFECTIONS  
7.1.  Abstract 
 The experiments described in this chapter were carried out to find out the 
subpopulations of T cells producing IFN-γ and/or IL-10 in T. congolense-infected BALB/c 
mice. CD4+CD25-, CD4+CD25low and CD4+CD25high cells were sorted by FACS from the 
spleen cells collected from normal and T. congolense-infected BALB/c mice at day 6 post 
infection. These sorted cells were cocultured with trypanosome-loaded peritoneal 
macrophages obtained from normal syngeneic BALB/c mice to find out the production levels 
of IFN-γ in these cocultures. The majority of IFN-γ was produced by CD4+CD25high cells 
cocultured with trypanosome-loaded peritoneal macrophages. In titration studies, detectable 
levels of IFN-γ and IL-10 were produced by adding 5x103 to 5x104 sorted T cells to the 
peritoneal macrophage cultures. The maximal production was observed with 5x104 sorted T 
cells when cocultured with macrophages. Equal levels of IFN-γ were observed when 5x104 
CD4+CD25low or 5x104 CD4+CD25high T cells cocultured with macrophages. Trypanosome-
loaded macrophages when cultured without sorted T cells did not show IL-10 production. 
There were no detectable amounts of IL-6 production when the macrophages were cultured 
alone. IL-6 production did not show much difference between the different cocultures but 
showed a slight dose-dependent increase with the increased numbers of T cells. 
105 APC when cocultured with 5x104 CD4+CD25+ cells produced the highest amount 
of IFN-γ and IL-10.  The production of IFN-γ and IL-10 was also well within the measurable 
range when 105 APC were cocultured with 1.7x104 CD4+CD25+ cells in 96-well flat bottom 
tissue culture plates. None of the measured cytokines were produced in detectable levels when 
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the MACS-sorted CD4+CD25+ cells were cultured alone. The coculture experiments indicated 
that the majority of IL-6 was produced by APC. IL-6 production did not show a strong 
correlation with the numbers of T cells in the cocultures suggesting that IL-6 production is 
only weakly T cell-dependent. The amounts of IFN-γ produced in the cocultures of 105 APC 
with either 5x104 CD4+CD25+ cells or 5x104 whole spleen cells were similar. This suggests 
that there might be cofactors present in the whole spleen cell population which might not be 
present or present only at lower levels in T cell enriched populations. We speculate these 
cofactors might influence the production of IFN-γ.   
7.2. Introduction 
 I tried to further characterize the small T cell population that is involved in the 
production of IFN-γ and IL-10. CD4+CD25-, CD4+CD25low and CD4+CD25high T cells isolated 
by FACS from the spleen cells of normal and T. congolense-infected BALB/c mice were co-
cultured with trypanosome-loaded peritoneal macrophages. In preliminary experiments, the 
majority of IFN-γ was shown to be produced by CD4+CD25high T cells. But I was unable to 
establish an optimal T cell number to be added onto the cocultures due to practical difficulties 
encountered during FACS sorting. We speculate CD4+CD25+ T cells to be the major IFN-γ 
producers.  Attempts to sort the CD4+CD25+ T cells, using mouse Treg isolation kits (Milteny 
Biotec), were not successful since this protocol failed to enrich the major IFN-γ producing 
cells.  
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7.3. Materials and Methods 
7.3.1. Mice 
Female BALB/c mice and CD1 mice were obtained from the Animal Resource Center of the 
University of Saskatchewan. BALB/c mice were 8 to 10 weeks old and CD1 mice were 6 
weeks old. All mice were maintained according to the recommendations of the Canadian 
Council of Animal Care.  
7.3.2. Parasites 
T. congolense, variant antigenic type (VAT) TC13 (Tabel, 1982) was used in this experiment. 
TC13 was passaged in immunosuppressed CD1 mice as described (Tabel, 1982). The parasites 
for the infection of BALB/c mice were obtained by isolating the parasites from the blood of 
infected CD1 mice using DEAE-cellulose chromatography column (Lanham and Godfrey, 
1970).  
7.3.3. Trypanosome homogenate 
Trypanosomes isolated from the blood of infected CD1 mice using DEAE-cellulose 
chromatography column were washed and resuspended in RPMI-1640 complete medium 
supplemented with 10% FBS at 107 trypanosomes/ 100 μl. The trypanosome suspension was 
sonicated 10 times at 5 seconds each time with 10 seconds intervals while keeping the 
suspension on ice. The homogenate was divided into aliquots of 100 μl portions and stored at -
800C until use.  
7.3.4. Antibodies  
The following principle antibodies were used for FACS analysis: FITC rat anti-mouse CD4 
(Cedarlane Laboratories), PE rat anti-mouse CD25 (eBioscience), PECy5 rat anti-mouse CD25 
(eBioscience) and PECy5 Armenian hamster anti-mouse CD3 (BD Pharmingen). The following 
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antibodies were used as isotype control antibodies:  FITC rat IgG2a (eBioscience), PErat IgG2a 
(eBioscience), PECy5rat IgG1 (eBioscience) and PECy5 Armenian hamster IgG (eBioscience).  
7.3.5. Preparation of Antigen Presenting Cells (APC) 
Peritoneal cells were collected from 8-10 weeks old normal female BALB/c mice, using filter-
sterilized 0.34 M sucrose solution. The cells spun at 1000 rpm for 10 minutes were 
resuspended in FACS staining buffer (PBS pH 7.2, 0.5% BSA and 2 mM EDTA) and stained 
with MACS anti-Thy 1.2 micro beads. Thy1.2 negative cells were purified by MACS 
separation using a MS column according to the manufacturer’s protocol. Cells in the negative 
fraction were counted and resuspended in RPMI-1640 complete medium supplemented with 
10% FBS.  
7.3.6. Sorting of CD4+CD25-, CD4+CD25low and CD4+CD25high cells from the spleen cells 
by FACS 
First, CD4+ cells were isolated by positive selection from spleen cells collected from normal 
and T. congolense-infected BALB/c mice at day 6 post infection, using MACS anti-CD4 
microbeads (Miltenyi Biotec) according to the manufacturer’s protocol. The purity of the 
enriched CD4+ cell population was 87% as detected by FACS. The enriched CD4+ cells were 
then stained with FITCanti-CD4 and PECy5anti-CD25. The stained cells were sorted into 
CD4+CD25-, CD4+CD25low and CD4+CD25high cells by FACS. Sorted cells were counted, 
resuspended in appropriate volumes of RPMI-1640 complete medium supplemented with 10% 
FBS cocultured with 5x105 APC per well in the presence of a trypanosome homogenate 
(equivalent to 106 organisms) in 96 well flat bottom tissue culture plates.  
7.3.7. Isolation of CD4+CD25+ Tregs from the spleen cells by MACS 
Spleen cells collected from four T. congolense-infected BALB/c mice at day 7 post infection 
were subjected to lysis of red blood cells and trypanosomes by mixing the cell suspension in   
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sterile distilled water for 20 seconds followed by addition of 10X PBS. These cells were used 
for the isolation of CD4+CD25+ Tregs using a Mouse Treg Isolation Kit (Miltenyi Biotec) 
according the manufacturer’s protocol. The cells were resuspended in RPMI-1640 complete 
medium supplemented with 10% FBS and seeded in 96 well flat bottom tissue culture plates at 
either 5 X 104 cells/well, 1.7 X 104 cells/well, 5 X 103 cells/well or 1.7 X 103 cells/well. 
Aliquots of cells from spleen cells, enriched for CD4+ cells or CD4+CD25+ cells were stained 
with FITCanti-CD4 and PEanti-CD25 to analyze by FACS. The enriched CD4+CD25+ group had 
70% purity as detected by FACS (Fig.7.7).   
7.3.8. Block titration of APC and CD4+CD25+ T cells 
APC and CD4+CD25+ T cells were cocultured in order to do a block titration to find out the 
optimal numbers of each cell type to be used in future coculture studies. The APC were seeded 
in 96 well flat bottom tissue culture plates at either 104 cells/well, 3.3 X 104 cells/well or 105 
cells/well. Aliquots of cells before and after MACS separation were stained with PECy5anti-
CD3 for FACS analysis. A homogenate equivalent to 106 trypanosomes was added to each 
well and the cells were incubated for 48 hours at 370C and 5%CO2. APC alone, CD4+CD25+ T 
cells alone and 105 APC with 5 X 104 whole spleen cells were included as control groups. The 
culture supernatants collected after 48 hours were used to measure the production of IFN-γ, 
IL-10 and IL-6 by routine sandwich ELISA according to the manufacturer’s protocols. 
7.3.9. Cytokine assays 
The levels of IL-6, IL-10 and IFN-γ in the culture supernatants were determined by routine 
sandwich ELISA, according to the manufacturer’s protocols. The ELISA kits were purchased 
from BD Pharmingen. The limits of detection of the ELISA assays were 62 pg/ml for IFN-γ 
and 15 pg/ml for IL-6 and IL-10.  
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7.3.10. FACS analysis 
One hundred microliter aliquots of 107 cells/ml in FACS buffer were incubated for 20 minutes 
on ice with 4 μl of rat anti-mouse CD16/32 (Fcγ II/III receptor, Fc Block, eBioscience) 
monoclonal antibody. Appropriate volumes of each antibody were added and incubated on ice 
in the dark for 30 minutes. The cells were washed 2 times with FACS buffer, and then 
resuspended in FACS buffer containing 1% formalin. Fixed cells were analyzed by a 
FACScan flow cytometer using Flowjo software (Tree Star Inc.).   
 
7.4. Results 
7.4.1. CD4+CD25high T cells cocultivated with T. congolense-loaded macrophages    
produce IFN-γ 
In preliminary experiments, CD4+CD25-, CD4+CD25low and CD4+CD25high T cells 
were sorted by a combination of MACS and FACS from the spleen cells of normal and T. 
congolense-infected BALB/c mice and were co-cultured with trypanosome-loaded peritoneal 
macrophages obtained from normal syngeneic BALB/c mice. The majority of IFN-γ was 
shown to be produced by CD4+CD25high T cells (Fig.7.1). None of the other cocultures 
produced high amounts of IFN-γ. There were no distinguishable CD25low and CD25high cell 
populations in normal mouse spleen cells when analyzed by FACS. Therefore, from normal 
mouse spleen cells, CD4+CD25- and CD4+CD25+ cells were sorted and cocultured with 
trypanosome-loaded syngeneic peritoneal macrophages. Culture supernatants were used in 2-
fold dilutions in ELISA in order to make sure that the cytokine levels to fit within a 
measurable range. Gates used for FACS cell sorting is shown in Fig. 7.2.     
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CD4+CD25high T cells cocultivated with T.congolense- loaded 
macrophages produce IFN-γ  
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Fig 7.1. Peritoneal macrophages (5x105/well) loaded with T. congolense were cocultured 
with 2x104 CD4+CD25-, CD4+CD25low or CD4+CD25high T cells. The cells were isolated 
from spleen cells of normal BALB/ mice and from infected BALB/C mice 6 days post 
infection. The T cells were sorted by a combination of MACS and FACS from the spleen 
cells. Culture supernatants collected after 48 hrs were used in undiluted form (neat) and in 
3 different dilutions (1:2, 1:4, and 1:8) in ELISA to measure the production of IFN-γ.  
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Fig.7.2. FACS sorting of CD25-, CD25low and CD25high cells. CD4+ cells were positively 
selected from the spleen cells of normal (A) and T. congolense-infected BALB/c mice (B), by 
MACS. CD4+ cells were stained with PECy5 rat anti-mouse CD25 to sort by FACS. The purity 
of the enriched CD4+ cell population was 87% as detected by FACS.  
 
7.4.2. What are the optimal numbers of T cells to be used in cocultures? 
 The next aim was to find out the optimal number of sorted cells to be cocultured with 
5x105 peritoneal macrophages in order to obtain detectable levels of the cytokine production. 
Therefore 5x104, 1.7x104, 5x103 and 1.7x103 of FACS-sorted CD4+CD25-, CD4+CD25low and 
CD4+CD25high T cells were co-cultured with 5x105 trypanosome-loaded, peritoneal 
macrophages. The culture supernatant fluids were tested for IL-6, IL-10 and IFN-γ by ELISA. 
Only the CD4+CD25-, CD4+CD25low and CD4+CD25high T cells sorted from the spleen cells of 
T. congolense-infected BALB/c mice were co-cultured with trypanosome-loaded peritoneal 
macrophages obtained from normal syngeneic BALB/c mice in this experiment. Since the 
CD4+CD25- and CD4+CD25+ T cells sorted from normal BALB/c mice had previously shown 
negligible amounts of IFN-γ  production in the cocultures, I did not include these cells in this 
experiment.  
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 Detectable levels of IFN-γ and IL-10 were produced by adding 5x103 to 5x104 sorted T 
cells to the macrophage cultures. The maximal production was observed with 5x104 sorted T 
cells when cocultured with macrophages (Fig. 7.3.A and B). It seemed that the production of 
almost equal levels of IFN-γ was observed when 5x104 CD4+CD25low and 5x104 
CD4+CD25high T cells were cocultured with macrophages (Fig.7.3.B). I speculate that the 
measurement of equal levels of IFN-γ  in these cases were not quite accurate due to a technical 
problem of the ELISA assays, since the IFN-γ values were higher than the highest IFN-γ value 
(2000 pg/ml) of the standard curve. 1.7x104 or lower numbers of CD4+CD25high T cells 
produced higher amounts of IFN-γ than equivalent numbers of CD4+CD25low cells (Fig. 7.3. 
B).  
Macrophages alone did not produce detectable levels of any of the cytokines measured. 
Trypanosome-loaded macrophages when cultured without T cells did not produce detectable 
amounts of IFN-γ. This is not surprising, since T cells are known to be the major producers of 
IFN-γ (Uzonna et al., 1998c). Trypanosome-loaded macrophages when cultured without T 
cells did not show IL-10 production, suggesting that T cell interaction with macrophages 
might be necessary for the production of IL-10 by macrophages and/or T cells.  There were 
no detectable amounts of IL-6 production when the macrophages were cultured alone. IL-6 
production did not show much difference between the different cocultures. The production of 
IL-6 was less in trypanosome-loaded macrophages when cultured without adding sorted T 
cells (Fig. 7.3.C). IL-6 can be secreted by T cells as well as macrophages. The observed 
pattern of IL-6 levels in these cocultures would indicate that most of the IL-6 was produced by 
macrophages. 
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Fig. 7.3. Peritoneal macrophages (5x105/well) loaded with  T. congolense were cocultured 
with 5x104 ,1.7x104 , 5x103 and 1.7x103 CD4+CD25-,CD4+CD25low and CD4+CD25high T cells 
sorted from spleen cells of infected BALB/C mice 6 days post infection. Supernatants 
collected after 48 hrs of culture were used in undiluted form to measure the production of IL-
10 (A) and 1:2 dilutions to measure IFN-γ (B) and IL-6 (C) in ELISA. 
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7.4.3. Block titration of APC and CD4+CD25+ T cells 
 There were difficulties in sorting sufficient numbers of cells from a group of mice to 
have enough replicates to continue the above experiment (Fig.7.3). The cell sorting produced 
variable results. It is a time consuming and expensive procedure. Therefore, a block titration 
was done using CD4+CD25+ cells enriched from spleen cells of T. congolense-infected 
BALB/c mice at day 6 post infection by MACS using a mouse Treg isolation kit. CD4+CD25- 
cells were not included for this block titration since none of the previous preliminary 
experiments showed a clear production of IFN-γ or IL-10 in the cocultures of CD4+CD25- 
cells and peritoneal macrophages. The enriched CD4+CD25+ cell population was 70% pure as 
detected by FACS (Fig.7.7).   
According to the results of this experiment, 105 APC when cocultured with 5x104 
CD4+CD25+ cells produced the highest amount of IFN-γ and IL-10.  The production of IFN-γ 
and IL-10 was also well within the measurable range when 105 APC were cocultured with 
1.7x104 CD4+CD25+ cells (Fig.7.4 and Fig.7.5 ). None of the measured cytokines were 
produced in detectable levels when the MACS-sorted CD4+CD25+ cells were cultured alone 
suggesting that the synergy of both T cells and macrophages are required for the production of 
these cytokines. It has been known that IFN-γ is mainly produced by T cells while both 
macrophages and T cells produce IL-6 and IL-10. IL-6 production increased more with the 
increase of APC numbers than with the increase of T cell numbers in the cocultures (Fig.7.6). 
This would indicate that the majority of IL-6 in these cocultures was produced by APC.  
The number of CD4+CD25+ cells in 5x104 cells of the enriched cell group should be 
higher than the number of CD4+CD25+ cells in 5x104 whole spleen cells. Therefore, IFN-γ 
production would be expected to be higher in cocultures of APC with enriched 
CD4+CD25+cells. But the productions of IFN-γ were almost similar in cultures of 105 APC 
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when cocultured with 5x104 CD4+CD25+ cells as when cocultured with 5x104 whole spleen 
cells. Thus, there might be cofactors in the whole spleen cell population that enhance the 
production of IFN-γ. The enriched cells might contain less cofactors compared to those of 
whole spleen cells.  
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Fig.7.4. Block titration to determine cell concentrations and ratios for optimal synthesis 
of IFN-γ in vitro. Antigen presenting cells (APC), obtained from the peritoneal cells (depleted 
of Thy1.2+ cells), were loaded with 106 equivalents of trypanosome homogenate per well and 
cocultured with different numbers of CD4+CD25+ cells from BALB/c mice infected with T. 
congolense for 6 days, enriched by using Mouse Treg Isolation Kit (Miltenyi Biotec).The 
culture supernatants (1:2 dilution) collected after 48 hours were used to measure the 
production of IFN-γ by routine sandwich ELISA. Values represent mean ± standard error of 
the samples obtained from 4 mice. (Representative results of two experiments). 
 
143 
 
IL-10 production
0
100
200
300
400
500
600
700
800
900
5x
10
e4
1.
7x
10
e4
5x
10
e3
1.
7x
10
e3 0
5x
10
e4
1.
7x
10
e4
5x
10
e3
1.
7x
10
e3 0
5x
10
e4
1.
7x
10
e4
5x
10
e3
1.
7x
10
e3 0
sp
le
en
 c
el
ls
 5
x1
0e
4 
5x
10
e4
1.
7x
10
e4
5x
10
e3
1.
7x
10
e3
10e4 APC+ 3.3x10e4 APC+ 10e5 APC+ 0 APC+
 p
g/
m
l
 
 
 
Fig. 7.5. Block titration to determine cell concentrations and ratios for optimal synthesis 
of IL-10 in vitro. Antigen presenting cells (APC), obtained from the peritoneal cells (depleted 
of Thy1.2+ cells), were loaded with 106 equivalents of trypanosome homogenate per well and 
cocultured with different numbers of CD4+CD25+ cells from BALB/c mice infected with T. 
congolense for 6 days, enriched by using Mouse Treg Isolation Kit (Miltenyi Biotec).The 
culture supernatants collected after 48 hours were used to measure the production of IL-10 by 
routine sandwich ELISA. Values represent mean ± standard error of the samples obtained 
from 4 mice. (Representative results of two experiments).  
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Fig.7.6. Block titration to determine cell concentrations and ratios for optimal synthesis 
of IL-6 in vitro. Antigen presenting cells (APC), obtained from the peritoneal cells (depleted 
of Thy1.2+ cells), were loaded with 106 equivalents of trypanosome homogenate per well and 
cocultured with different numbers of CD4+CD25+ cells from BALB/c mice infected with T. 
congolense for 6 days, enriched by using Mouse Treg Isolation Kit (Miltenyi Biotec).The 
culture supernatants (1:2 dilution) collected after 48 hours were used to measure the 
production of IL-6 by routine sandwich ELISA. Values represent mean ± standard error of the 
samples obtained from 4 mice. (Representative results of two experiments).  
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Fig. 7.7. FACS analysis of the enriched CD4+ and CD4+CD25+ cell populations of the 
spleen of BALB/c mice 6 days after T. congolense infection.  Whole spleen cells stained 
with FITC rat anti-CD4 and PE rat anti-CD25 (A),  Enriched CD4+ cell fraction stained with FITC 
rat anti-CD4 and PE rat anti-CD25 (B)  and the enriched CD4+CD25+ cell population stained 
with FITC rat anti-CD4 and PE rat anti-CD25 (C) as detected by FACS analysis.   
 
7.5. Discussion 
In preliminary experiments, the CD4+CD25-, CD4+CD25low and CD4+CD25high T cells, 
sorted by FACS from the spleen cells of normal and T. congolense-infected BALB/c mice, 
were co-cultured with trypanosome-loaded peritoneal macrophages. The majority of IFN-γ 
was shown to be produced by CD4+CD25high T cells co-cultured with trypanosome-loaded 
peritoneal macrophages (Fig. 7.1). Although presently there is no direct experimental 
evidence, I speculate that these CD4+CD25high cells might be a small subpopulation of highly 
activated CD4+CR2+ T cells. Whether the IFN- γ and IL-10 was produced by different cell 
populations or the same T cells is unknown. There is a body of evidence that T cells with 
regulatory functions can be double producers, i.e., produce both IL-10 and IFN-γ (Trinchieri, 
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2001). Such T cells have been found in humans (Pohl-Koppe et al., 1998; Winkler et al., 1998; 
Gerosa et al., 1999; Cella et al., 2000; Kadowaki et al., 2000; Levings et al., 2001) and mice 
(Ganapamo et al., 2000; Belkaid et al., 2001) infected with viruses, bacteria or protozoa. 
CD4+CD25- and CD4+CD25+ T cells sorted from normal BALB/c mice showed 
negligible amounts of IFN-γ  production in the cocultures suggesting that IFN-γ  production is 
trypanosome-specific (Fig.7.1).  Detectable levels of IFN-γ and IL-10 were produced by 
adding 5x103 to 5x104 sorted T cells to the macrophage cultures while the maximal production 
was observed with 5x104 sorted T cells when cocultured with macrophages (Fig.7.2). In 
subsequent experiments, production of almost equal levels of IFN-γ was observed in titration 
studies when 5x104 CD4+CD25low and CD4+CD25high T cells were cocultured with 
macrophages (Fig.7.3). Trypanosome-loaded macrophages, when cultured without sorted T 
cells, did not produce detectable amounts of IFN-γ. This would confirm that the T cells are the 
major producers of IFN-γ. Macrophages alone or trypanosome-loaded macrophages when 
cultured without sorted T cells did not show IL-10 production (Fig.7.3), suggesting that T cell 
interaction might be necessary for the production of IL-10 by the macrophages and/or T cells.  
IL-6 is secreted by T cells and macrophages. BMDM from BALB/c mice produced 
significantly more IL-6 and IL-10 than those from C57BL/6 mice indicating that cytokine 
genes are differentially regulated in macrophages from trypanosome-susceptible and -resistant 
mice (Kaushik et al., 2000).The observed increase of IL-6 levels in trypanosome-loaded 
macrophages and sorted T cells cocultures (Fig.7.6) could be due to either the production of 
IL-6 by the added T cells and/or by macrophages when they get T cell stimulation. The 
production of IL-6 did not show a strong correlation with the numbers of added T cells. This 
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suggests that IL-6 production is somewhat T cell interaction-dependent but IL-6 is mostly 
synthesized by the macrophages. 
According to the results of block titration experiment, cocultures of 105 APC and 
5x104 CD4+CD25+ cells produced the highest amount of IFN-γ and IL-10 (Fig.7.4 and 7.5.).  
The production of IFN-γ and IL-10 was also well within the measurable range when 105 APC 
were cocultured with 1.7x104 CD4+CD25+ cells. None of the measured cytokines were 
produced in detectable levels when the MACS-sorted CD4+CD25+ cells were cultured alone, 
suggesting that the synergy of both T cells and macrophages are required for the production of 
these cytokines. IFN-γ is mainly produced by T cells while both macrophages and T cells 
produce IL-6 and IL-10. Increase of IL-6 production with the increase of APC number 
(Fig.7.6) indicates that the majority of IL-6 in these cocultures was produced by APC. The 
production of IFN-γ was similar in 105 APC when cocultured with 5x104 CD4+CD25+ cells 
and 105 APC when cocultured with 5x104 whole spleen cells (Fig.7.4). This result suggests 
that there might be certain cofactors present in the whole spleen cells which can enhance 
production of IFN-γ, but there might have been less cofactors in the enriched cell populations.  
 
 
 
 
 
 
 
